CA2407093A1 - Substituted phenyl farnesyltransferase inhibitors - Google Patents
Substituted phenyl farnesyltransferase inhibitors Download PDFInfo
- Publication number
- CA2407093A1 CA2407093A1 CA002407093A CA2407093A CA2407093A1 CA 2407093 A1 CA2407093 A1 CA 2407093A1 CA 002407093 A CA002407093 A CA 002407093A CA 2407093 A CA2407093 A CA 2407093A CA 2407093 A1 CA2407093 A1 CA 2407093A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- imidazol
- group
- desired product
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title description 27
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 327
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- -1 amino, hydroxyl Chemical group 0.000 claims description 317
- 229910052757 nitrogen Inorganic materials 0.000 claims description 55
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 44
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 39
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 39
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 37
- 125000001072 heteroaryl group Chemical group 0.000 claims description 35
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 34
- 125000003545 alkoxy group Chemical group 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 125000002947 alkylene group Chemical group 0.000 claims description 28
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 27
- 229920001774 Perfluoroether Polymers 0.000 claims description 26
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 26
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 24
- 125000003118 aryl group Chemical group 0.000 claims description 23
- 125000001589 carboacyl group Chemical group 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 23
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 23
- 125000004423 acyloxy group Chemical group 0.000 claims description 22
- 125000005518 carboxamido group Chemical group 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 18
- 229910052717 sulfur Inorganic materials 0.000 claims description 16
- 229910052727 yttrium Inorganic materials 0.000 claims description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 8
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 8
- 125000004043 oxo group Chemical group O=* 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims description 5
- 125000002883 imidazolyl group Chemical group 0.000 claims description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 5
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 5
- 125000000335 thiazolyl group Chemical group 0.000 claims description 5
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 125000001425 triazolyl group Chemical group 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 4
- 125000004419 alkynylene group Chemical group 0.000 claims description 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 3
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 3
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 claims description 3
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims description 3
- 229910052721 tungsten Inorganic materials 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 6
- 238000000034 method Methods 0.000 abstract description 69
- 238000011282 treatment Methods 0.000 abstract description 42
- 108010007508 Farnesyltranstransferase Proteins 0.000 abstract description 26
- 102000007317 Farnesyltranstransferase Human genes 0.000 abstract description 26
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 411
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 344
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 321
- 238000005160 1H NMR spectroscopy Methods 0.000 description 314
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 293
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 266
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 246
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 211
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 186
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 162
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 147
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 139
- 239000012141 concentrate Substances 0.000 description 118
- 235000008504 concentrate Nutrition 0.000 description 118
- 239000000243 solution Substances 0.000 description 114
- 229910001868 water Inorganic materials 0.000 description 106
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 95
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 93
- 101150041968 CDC13 gene Proteins 0.000 description 92
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 78
- 239000000741 silica gel Substances 0.000 description 74
- 229910002027 silica gel Inorganic materials 0.000 description 74
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 70
- 238000003818 flash chromatography Methods 0.000 description 67
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 67
- 239000004305 biphenyl Substances 0.000 description 64
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 55
- 235000010290 biphenyl Nutrition 0.000 description 51
- 239000012267 brine Substances 0.000 description 46
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 46
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- 239000000203 mixture Substances 0.000 description 39
- 238000000746 purification Methods 0.000 description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 38
- CVKOOKPNCVYHNY-UHFFFAOYSA-N 3-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC(C#N)=C1 CVKOOKPNCVYHNY-UHFFFAOYSA-N 0.000 description 35
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 35
- WLPATYNQCGVFFH-UHFFFAOYSA-N 2-phenylbenzonitrile Chemical compound N#CC1=CC=CC=C1C1=CC=CC=C1 WLPATYNQCGVFFH-UHFFFAOYSA-N 0.000 description 34
- 239000000284 extract Substances 0.000 description 32
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 229920006395 saturated elastomer Polymers 0.000 description 30
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 29
- 241000124008 Mammalia Species 0.000 description 28
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 26
- 125000005843 halogen group Chemical group 0.000 description 26
- XXRUQNNAKXZSOS-UHFFFAOYSA-N 5-(chloromethyl)-1,2,3-trimethoxybenzene Chemical compound COC1=CC(CCl)=CC(OC)=C1OC XXRUQNNAKXZSOS-UHFFFAOYSA-N 0.000 description 25
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 25
- 239000000908 ammonium hydroxide Substances 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 206010028980 Neoplasm Diseases 0.000 description 24
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 20
- FAHZIKXYYRGSHF-UHFFFAOYSA-N 3-bromo-4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1Br FAHZIKXYYRGSHF-UHFFFAOYSA-N 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 20
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 20
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 20
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 20
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 19
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 17
- 201000011510 cancer Diseases 0.000 description 16
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 16
- 230000035484 reaction time Effects 0.000 description 16
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 15
- 239000003937 drug carrier Substances 0.000 description 13
- 239000010410 layer Substances 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 12
- MIHBFANPMPEZEI-UHFFFAOYSA-N benzonitrile dihydrochloride Chemical compound Cl.Cl.N#CC1=CC=CC=C1 MIHBFANPMPEZEI-UHFFFAOYSA-N 0.000 description 11
- UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 10
- 239000005909 Kieselgur Substances 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 9
- 125000001624 naphthyl group Chemical group 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
- USYQKCQEVBFJRP-UHFFFAOYSA-N 1-bromo-3-phenylbenzene Chemical group BrC1=CC=CC(C=2C=CC=CC=2)=C1 USYQKCQEVBFJRP-UHFFFAOYSA-N 0.000 description 8
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 8
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 8
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 7
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 7
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical group FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 6
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- 125000001715 oxadiazolyl group Chemical group 0.000 description 6
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 102000016914 ras Proteins Human genes 0.000 description 6
- 108010014186 ras Proteins Proteins 0.000 description 6
- VFWRGKJLLYDFBY-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag].[Ag] VFWRGKJLLYDFBY-UHFFFAOYSA-N 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- SVBBQSMUEOIQDZ-UHFFFAOYSA-N ethyl 3-bromo-4-cyanobenzoate Chemical group CCOC(=O)C1=CC=C(C#N)C(Br)=C1 SVBBQSMUEOIQDZ-UHFFFAOYSA-N 0.000 description 4
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 108010050749 geranylgeranyltransferase type-I Proteins 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 4
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229940002612 prodrug Drugs 0.000 description 4
- 239000000651 prodrug Substances 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 4
- 229960004528 vincristine Drugs 0.000 description 4
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 4
- PXGQMYCEAWZJJF-UHFFFAOYSA-N (3-methylimidazol-4-yl)methanol Chemical compound CN1C=NC=C1CO PXGQMYCEAWZJJF-UHFFFAOYSA-N 0.000 description 3
- MWZDIEIXRBWPLG-UHFFFAOYSA-N 1-methyl-1,2,4-triazole Chemical compound CN1C=NC=N1 MWZDIEIXRBWPLG-UHFFFAOYSA-N 0.000 description 3
- HFACYWDPMNWMIW-UHFFFAOYSA-N 2-cyclohexylethanamine Chemical compound NCCC1CCCCC1 HFACYWDPMNWMIW-UHFFFAOYSA-N 0.000 description 3
- DTHIZBJCEUNEKZ-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-nitrophenyl)methylamino]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(NCC=2C=CC(=CC=2)[N+]([O-])=O)C=2N(C=NC=2)C)=CC=C1C#N DTHIZBJCEUNEKZ-UHFFFAOYSA-N 0.000 description 3
- JWBXEAWAKPENHL-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-isoquinolin-5-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=NC=C2C=CC=1)OCC1=CC=C(C#N)C=C1 JWBXEAWAKPENHL-UHFFFAOYSA-N 0.000 description 3
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000007832 Na2SO4 Substances 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- JXHYCCGOZUGBFD-UHFFFAOYSA-N benzoic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1 JXHYCCGOZUGBFD-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- FCYRSDMGOLYDHL-UHFFFAOYSA-N chloromethoxyethane Chemical compound CCOCCl FCYRSDMGOLYDHL-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006126 farnesylation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 125000001786 isothiazolyl group Chemical group 0.000 description 3
- 125000000842 isoxazolyl group Chemical group 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- 125000002757 morpholinyl group Chemical group 0.000 description 3
- 125000002971 oxazolyl group Chemical group 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 125000003386 piperidinyl group Chemical group 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- 229960004618 prednisone Drugs 0.000 description 3
- 238000002953 preparative HPLC Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 125000002098 pyridazinyl group Chemical group 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- XMIAFAKRAAMSGX-UHFFFAOYSA-N quinolin-5-amine Chemical compound C1=CC=C2C(N)=CC=CC2=N1 XMIAFAKRAAMSGX-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 125000001113 thiadiazolyl group Chemical group 0.000 description 3
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 3
- 125000004306 triazinyl group Chemical group 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- RRCMGJCFMJBHQC-UHFFFAOYSA-N (2-chlorophenyl)boronic acid Chemical group OB(O)C1=CC=CC=C1Cl RRCMGJCFMJBHQC-UHFFFAOYSA-N 0.000 description 2
- IKSNDOVDVVPSMA-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(CBr)C=C1 IKSNDOVDVVPSMA-UHFFFAOYSA-N 0.000 description 2
- KQNBRMUBPRGXSL-UHFFFAOYSA-N 1-(bromomethyl)-4-chlorobenzene Chemical compound ClC1=CC=C(CBr)C=C1 KQNBRMUBPRGXSL-UHFFFAOYSA-N 0.000 description 2
- LXPRVXKHIXWBJZ-UHFFFAOYSA-N 1-(chloromethyl)-4-methylsulfonylbenzene Chemical group CS(=O)(=O)C1=CC=C(CCl)C=C1 LXPRVXKHIXWBJZ-UHFFFAOYSA-N 0.000 description 2
- NZAXGZYPZGEVBD-UHFFFAOYSA-N 1-benzoylpiperidin-4-one Chemical group C=1C=CC=CC=1C(=O)N1CCC(=O)CC1 NZAXGZYPZGEVBD-UHFFFAOYSA-N 0.000 description 2
- LECYCYNAEJDSIL-UHFFFAOYSA-N 1-bromo-2-propan-2-ylbenzene Chemical compound CC(C)C1=CC=CC=C1Br LECYCYNAEJDSIL-UHFFFAOYSA-N 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- ZQEXIXXJFSQPNA-UHFFFAOYSA-N 1h-imidazole-5-carbaldehyde Chemical compound O=CC1=CNC=N1 ZQEXIXXJFSQPNA-UHFFFAOYSA-N 0.000 description 2
- IRSVDHPYXFLLDS-UHFFFAOYSA-N 2,4-dichloro-1-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1Cl IRSVDHPYXFLLDS-UHFFFAOYSA-N 0.000 description 2
- CSTUTNIOZWDJAH-UHFFFAOYSA-N 2-(2-methylphenyl)-4-[phenylmethoxy(thiophen-3-yl)methyl]benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C2=CSC=C2)=CC=C1C#N CSTUTNIOZWDJAH-UHFFFAOYSA-N 0.000 description 2
- JRHMPHMGOGMNDU-UHFFFAOYSA-N 2-(bromomethyl)-1-methoxy-4-nitrobenzene Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CBr JRHMPHMGOGMNDU-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- WCXUCQOJYIZMEI-UHFFFAOYSA-N 2-anthracen-9-yl-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=C2C=CC=CC2=1)OCC1=CC=CC=C1 WCXUCQOJYIZMEI-UHFFFAOYSA-N 0.000 description 2
- CWVONUMJRUZWAX-UHFFFAOYSA-N 2-naphthalen-1-ylbenzonitrile Chemical compound N#CC1=CC=CC=C1C1=CC=CC2=CC=CC=C12 CWVONUMJRUZWAX-UHFFFAOYSA-N 0.000 description 2
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 2
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 125000006032 3-methyl-3-butenyl group Chemical group 0.000 description 2
- XDKGMGJZRFOZRV-UHFFFAOYSA-N 4-(bromomethyl)-2,6-dichloropyridine Chemical compound ClC1=CC(CBr)=CC(Cl)=N1 XDKGMGJZRFOZRV-UHFFFAOYSA-N 0.000 description 2
- NDILXQGKNNSWNQ-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenoxymethyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OC=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N NDILXQGKNNSWNQ-UHFFFAOYSA-N 0.000 description 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical group O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 2
- DQCXCJCPVFDTPQ-UHFFFAOYSA-N 4-formyl-2-iodobenzonitrile Chemical compound IC1=CC(C=O)=CC=C1C#N DQCXCJCPVFDTPQ-UHFFFAOYSA-N 0.000 description 2
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 2
- PBLOYQAQGYUPCM-UHFFFAOYSA-N 6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C=N1 PBLOYQAQGYUPCM-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical group CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 125000004054 acenaphthylenyl group Chemical group C1(=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 2
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- KVFDZFBHBWTVID-UHFFFAOYSA-N cyclohexanecarbaldehyde Chemical group O=CC1CCCCC1 KVFDZFBHBWTVID-UHFFFAOYSA-N 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- VJNQGXXEHMTDGA-UHFFFAOYSA-N ethyl 4-cyano-3-iodobenzoate Chemical compound CCOC(=O)C1=CC=C(C#N)C(I)=C1 VJNQGXXEHMTDGA-UHFFFAOYSA-N 0.000 description 2
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 2
- 229960005420 etoposide Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 201000005962 mycosis fungoides Diseases 0.000 description 2
- KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- VATYWCRQDJIRAI-UHFFFAOYSA-N p-aminobenzaldehyde Chemical compound NC1=CC=C(C=O)C=C1 VATYWCRQDJIRAI-UHFFFAOYSA-N 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 108010054353 p21(ras) farnesyl-protein transferase Proteins 0.000 description 2
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- KXJJSKYICDAICD-UHFFFAOYSA-N quinolin-8-ylboronic acid Chemical group C1=CN=C2C(B(O)O)=CC=CC2=C1 KXJJSKYICDAICD-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 238000002821 scintillation proximity assay Methods 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 2
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 2
- 239000012414 tert-butyl nitrite Substances 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000005309 thioalkoxy group Chemical group 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 2
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- OOMZKLJLVGQZGV-UHFFFAOYSA-N (2,5-dimethylphenyl)boronic acid Chemical compound CC1=CC=C(C)C(B(O)O)=C1 OOMZKLJLVGQZGV-UHFFFAOYSA-N 0.000 description 1
- PNVPNXKRAUBJGW-UHFFFAOYSA-N (2-chloroacetyl) 2-chloroacetate Chemical compound ClCC(=O)OC(=O)CCl PNVPNXKRAUBJGW-UHFFFAOYSA-N 0.000 description 1
- HYCYKHYFIWHGEX-UHFFFAOYSA-N (2-phenylphenyl)boronic acid Chemical group OB(O)C1=CC=CC=C1C1=CC=CC=C1 HYCYKHYFIWHGEX-UHFFFAOYSA-N 0.000 description 1
- GHPYJLCQYMAXGG-WCCKRBBISA-N (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid hydrochloride Chemical compound Cl.N[C@@H](CSCCB(O)O)C(O)=O GHPYJLCQYMAXGG-WCCKRBBISA-N 0.000 description 1
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- VCKUOSKDXLTBDG-DOTOQJQBSA-N (3r,4r)-4-hydroxy-3-methoxy-4-(4-methoxyphenyl)-1,3-dihydroquinolin-2-one Chemical compound C1([C@@]2(O)C3=CC=CC=C3NC(=O)[C@@H]2OC)=CC=C(OC)C=C1 VCKUOSKDXLTBDG-DOTOQJQBSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- 125000006033 1,1-dimethyl-2-propenyl group Chemical group 0.000 description 1
- RBYUCFIZMNKDGX-UHFFFAOYSA-N 1,2-dihydroacenaphthylen-5-ylboronic acid Chemical compound C1CC2=CC=CC3=C2C1=CC=C3B(O)O RBYUCFIZMNKDGX-UHFFFAOYSA-N 0.000 description 1
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 description 1
- ZFLRKAMKGYNFPH-UHFFFAOYSA-N 1,3-dichloro-5-(chloromethyl)benzene Chemical group ClCC1=CC(Cl)=CC(Cl)=C1 ZFLRKAMKGYNFPH-UHFFFAOYSA-N 0.000 description 1
- IGERFAHWSHDDHX-UHFFFAOYSA-N 1,3-dioxanyl Chemical group [CH]1OCCCO1 IGERFAHWSHDDHX-UHFFFAOYSA-N 0.000 description 1
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- MJUVRTYWUMPBTR-MRXNPFEDSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide Chemical compound FC=1C=C2N(C[C@@H](O)CO)C(C(C)(CO)C)=CC2=CC=1NC(=O)C1(C=2C=C3OC(F)(F)OC3=CC=2)CC1 MJUVRTYWUMPBTR-MRXNPFEDSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- PURSZYWBIQIANP-UHFFFAOYSA-N 1-(bromomethyl)-2-chlorobenzene Chemical group ClC1=CC=CC=C1CBr PURSZYWBIQIANP-UHFFFAOYSA-N 0.000 description 1
- FFWQLZFIMNTUCZ-UHFFFAOYSA-N 1-(bromomethyl)-2-fluorobenzene Chemical group FC1=CC=CC=C1CBr FFWQLZFIMNTUCZ-UHFFFAOYSA-N 0.000 description 1
- WGVYCXYGPNNUQA-UHFFFAOYSA-N 1-(bromomethyl)-2-methylbenzene Chemical group CC1=CC=CC=C1CBr WGVYCXYGPNNUQA-UHFFFAOYSA-N 0.000 description 1
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical group [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 1
- KVSVNRFSKRFPIL-UHFFFAOYSA-N 1-(bromomethyl)-3,5-difluorobenzene Chemical group FC1=CC(F)=CC(CBr)=C1 KVSVNRFSKRFPIL-UHFFFAOYSA-N 0.000 description 1
- QXDHXCVJGBTQMK-UHFFFAOYSA-N 1-(bromomethyl)-3,5-dimethylbenzene Chemical group CC1=CC(C)=CC(CBr)=C1 QXDHXCVJGBTQMK-UHFFFAOYSA-N 0.000 description 1
- QSIVWRRHVXSDNE-UHFFFAOYSA-N 1-(bromomethyl)-3-(trifluoromethoxy)benzene Chemical group FC(F)(F)OC1=CC=CC(CBr)=C1 QSIVWRRHVXSDNE-UHFFFAOYSA-N 0.000 description 1
- MYYYZNVAUZVXBO-UHFFFAOYSA-N 1-(bromomethyl)-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(CBr)=C1 MYYYZNVAUZVXBO-UHFFFAOYSA-N 0.000 description 1
- MYYYZNVAUZVXBO-ZFJHNFROSA-N 1-(bromomethyl)-3-(trifluoromethyl)benzene Chemical group FC(F)(F)[13C]1=[13CH][13CH]=[13CH][13C](CBr)=[13CH]1 MYYYZNVAUZVXBO-ZFJHNFROSA-N 0.000 description 1
- LZIYAIRGDHSVED-UHFFFAOYSA-N 1-(bromomethyl)-3-chlorobenzene Chemical group ClC1=CC=CC(CBr)=C1 LZIYAIRGDHSVED-UHFFFAOYSA-N 0.000 description 1
- SCBZBMXPJYMXRC-UHFFFAOYSA-N 1-(bromomethyl)-3-fluorobenzene Chemical group FC1=CC=CC(CBr)=C1 SCBZBMXPJYMXRC-UHFFFAOYSA-N 0.000 description 1
- BACZSVQZBSCWIG-UHFFFAOYSA-N 1-(bromomethyl)-3-iodobenzene Chemical group BrCC1=CC=CC(I)=C1 BACZSVQZBSCWIG-UHFFFAOYSA-N 0.000 description 1
- ZKSOJQDNSNJIQW-PTQBSOBMSA-N 1-(bromomethyl)-3-methoxybenzene Chemical group COC1=CC=CC([13CH2]Br)=C1 ZKSOJQDNSNJIQW-PTQBSOBMSA-N 0.000 description 1
- FWLWTILKTABGKQ-UHFFFAOYSA-N 1-(bromomethyl)-3-methylbenzene Chemical group CC1=CC=CC(CBr)=C1 FWLWTILKTABGKQ-UHFFFAOYSA-N 0.000 description 1
- JDNPUJCKXLOHOW-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethoxy)benzene Chemical compound FC(F)(F)OC1=CC=C(CBr)C=C1 JDNPUJCKXLOHOW-UHFFFAOYSA-N 0.000 description 1
- JMNOONULDANZRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluoro-2-(trifluoromethyl)benzene Chemical group FC1=CC=C(CBr)C(C(F)(F)F)=C1 JMNOONULDANZRZ-UHFFFAOYSA-N 0.000 description 1
- NVNPLEPBDPJYRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluorobenzene Chemical group FC1=CC=C(CBr)C=C1 NVNPLEPBDPJYRZ-UHFFFAOYSA-N 0.000 description 1
- BQTRMYJYYNQQGK-UHFFFAOYSA-N 1-(bromomethyl)-4-iodobenzene Chemical group BrCC1=CC=C(I)C=C1 BQTRMYJYYNQQGK-UHFFFAOYSA-N 0.000 description 1
- WZRKSPFYXUXINF-UHFFFAOYSA-N 1-(bromomethyl)-4-methylbenzene Chemical group CC1=CC=C(CBr)C=C1 WZRKSPFYXUXINF-UHFFFAOYSA-N 0.000 description 1
- QZNQSIHCDAGZIA-UHFFFAOYSA-N 1-(bromomethyl)-4-tert-butylbenzene Chemical group CC(C)(C)C1=CC=C(CBr)C=C1 QZNQSIHCDAGZIA-UHFFFAOYSA-N 0.000 description 1
- HEAQHTKDZPKODU-UHFFFAOYSA-N 1-(chloromethyl)-2,3,4-trimethoxybenzene Chemical compound COC1=CC=C(CCl)C(OC)=C1OC HEAQHTKDZPKODU-UHFFFAOYSA-N 0.000 description 1
- UYQPSKUPEXAQRJ-UHFFFAOYSA-N 1-(chloromethyl)-4-phenylmethoxybenzene Chemical group C1=CC(CCl)=CC=C1OCC1=CC=CC=C1 UYQPSKUPEXAQRJ-UHFFFAOYSA-N 0.000 description 1
- CYAKWEQUWJAHLW-UHFFFAOYSA-N 1-(chloromethyl)-4-propan-2-ylbenzene Chemical group CC(C)C1=CC=C(CCl)C=C1 CYAKWEQUWJAHLW-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- CWZUTHDJLNZLCM-DFBGVHRSSA-N 1-[2-[(1r,3s,5r)-3-[(6-bromopyridin-2-yl)carbamoyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazole-3-carboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)CN1N=C(C2=CC=CC=C21)C(=O)N)NC1=CC=CC(Br)=N1 CWZUTHDJLNZLCM-DFBGVHRSSA-N 0.000 description 1
- BNLRVFJSVGTTGG-UHFFFAOYSA-N 1-[3-(chloromethyl)-4-methoxyphenyl]ethanone Chemical group COC1=CC=C(C(C)=O)C=C1CCl BNLRVFJSVGTTGG-UHFFFAOYSA-N 0.000 description 1
- SJZKULRDWHPHGG-UHFFFAOYSA-N 1-benzylpiperidin-4-one Chemical group C1CC(=O)CCN1CC1=CC=CC=C1 SJZKULRDWHPHGG-UHFFFAOYSA-N 0.000 description 1
- WLPXNBYWDDYJTN-UHFFFAOYSA-N 1-bromo-2,3-dimethylbenzene Chemical group CC1=CC=CC(Br)=C1C WLPXNBYWDDYJTN-UHFFFAOYSA-N 0.000 description 1
- CMIMBQIBIZZZHQ-UHFFFAOYSA-N 1-bromo-2-methylnaphthalene Chemical compound C1=CC=CC2=C(Br)C(C)=CC=C21 CMIMBQIBIZZZHQ-UHFFFAOYSA-N 0.000 description 1
- KTADSLDAUJLZGL-UHFFFAOYSA-N 1-bromo-2-phenylbenzene Chemical group BrC1=CC=CC=C1C1=CC=CC=C1 KTADSLDAUJLZGL-UHFFFAOYSA-N 0.000 description 1
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical group BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical class CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- ZWLHKPCYGMMCFY-UHFFFAOYSA-N 1-iodoanthracene Chemical compound C1=CC=C2C=C3C(I)=CC=CC3=CC2=C1 ZWLHKPCYGMMCFY-UHFFFAOYSA-N 0.000 description 1
- XUKWOJNDLIOXSC-UHFFFAOYSA-N 1-methyl-2-oxopyridine-4-carboxylic acid Chemical compound CN1C=CC(C(O)=O)=CC1=O XUKWOJNDLIOXSC-UHFFFAOYSA-N 0.000 description 1
- JWAWEQBUZOGIBZ-UHFFFAOYSA-N 1-methyltriazole Chemical group CN1C=CN=N1 JWAWEQBUZOGIBZ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-M 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=C(S([O-])(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-M 0.000 description 1
- JASQNLDZUCSGKV-UHFFFAOYSA-N 2,4-dichloro-1-(iodomethyl)benzene Chemical compound ClC1=CC=C(CI)C(Cl)=C1 JASQNLDZUCSGKV-UHFFFAOYSA-N 0.000 description 1
- AFWNZBNOUYMUPY-UHFFFAOYSA-N 2-(1,2-dihydroacenaphthylen-5-yl)-4-formylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C=3C=CC=C4CCC(C=34)=CC=2)=C1 AFWNZBNOUYMUPY-UHFFFAOYSA-N 0.000 description 1
- CVHCLQXJULVHND-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)-4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1SC2=CC=CC=C2C=1)OCC1=CC=C(C#N)C=C1 CVHCLQXJULVHND-UHFFFAOYSA-N 0.000 description 1
- IUBYXJCTSDPMTH-UHFFFAOYSA-N 2-(2,3-dimethylphenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC(C=2C(=CC=C(C=2)C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)C#N)=C1C IUBYXJCTSDPMTH-UHFFFAOYSA-N 0.000 description 1
- BFICBOFPAIFGLM-UHFFFAOYSA-N 2-(2,3-dimethylphenyl)-4-formylbenzonitrile Chemical compound CC1=CC=CC(C=2C(=CC=C(C=O)C=2)C#N)=C1C BFICBOFPAIFGLM-UHFFFAOYSA-N 0.000 description 1
- BUTFDZXAAGTDRU-UHFFFAOYSA-N 2-(2,5-dimethylphenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CC1=CC=C(C)C(C=2C(=CC=C(C=2)C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)C#N)=C1 BUTFDZXAAGTDRU-UHFFFAOYSA-N 0.000 description 1
- BXECVVQAIBIOJT-UHFFFAOYSA-N 2-(2,5-dimethylphenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=C(C)C(C=2C(=CC=C(C=2)C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)C#N)=C1 BXECVVQAIBIOJT-UHFFFAOYSA-N 0.000 description 1
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 1
- UFIKXURYKMFEAA-UHFFFAOYSA-N 2-(2-chlorophenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)Cl)OCC1=CC=CC=C1 UFIKXURYKMFEAA-UHFFFAOYSA-N 0.000 description 1
- VSJYMOUXDQICJH-UHFFFAOYSA-N 2-(2-chlorophenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)Cl)OCC1=CC=CC=C1 VSJYMOUXDQICJH-UHFFFAOYSA-N 0.000 description 1
- VLWQGNUVANIMBH-UHFFFAOYSA-N 2-(2-ethylphenyl)-4-formylbenzonitrile Chemical compound CCC1=CC=CC=C1C1=CC(C=O)=CC=C1C#N VLWQGNUVANIMBH-UHFFFAOYSA-N 0.000 description 1
- CVBWBZNKXSKHPX-UHFFFAOYSA-N 2-(2-methoxyphenyl)-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile;hydrochloride Chemical compound Cl.COC1=CC=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N CVBWBZNKXSKHPX-UHFFFAOYSA-N 0.000 description 1
- UURHDQHGZOYDGW-UHFFFAOYSA-N 2-(2-methylphenyl)-4-(pyridin-3-ylmethylamino)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(NCC=2C=NC=CC=2)=CC=C1C#N UURHDQHGZOYDGW-UHFFFAOYSA-N 0.000 description 1
- LSJLKRCLZUGQLL-UHFFFAOYSA-N 2-(2-methylphenyl)-4-[(pyridin-3-ylamino)methyl]benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CNC=2C=NC=CC=2)=CC=C1C#N LSJLKRCLZUGQLL-UHFFFAOYSA-N 0.000 description 1
- KNUKAZNMAFHEGV-UHFFFAOYSA-N 2-(2-methylphenyl)-4-[phenylmethoxy(1,3-thiazol-5-yl)methyl]benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C=2SC=NC=2)=CC=C1C#N KNUKAZNMAFHEGV-UHFFFAOYSA-N 0.000 description 1
- PDFGFQUSSYSWNI-UHFFFAOYSA-N 2-(bromomethyl)-1,3-dichlorobenzene Chemical group ClC1=CC=CC(Cl)=C1CBr PDFGFQUSSYSWNI-UHFFFAOYSA-N 0.000 description 1
- ONWGSWNHQZYCFK-UHFFFAOYSA-N 2-(bromomethyl)-1,4-difluorobenzene Chemical group FC1=CC=C(F)C(CBr)=C1 ONWGSWNHQZYCFK-UHFFFAOYSA-N 0.000 description 1
- QGXNHCXKWFNKCG-UHFFFAOYSA-N 2-(bromomethyl)benzonitrile Chemical group BrCC1=CC=CC=C1C#N QGXNHCXKWFNKCG-UHFFFAOYSA-N 0.000 description 1
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LFFIEVAMVPCZNA-UHFFFAOYSA-N 2-[4-(bromomethyl)phenyl]benzonitrile Chemical group C1=CC(CBr)=CC=C1C1=CC=CC=C1C#N LFFIEVAMVPCZNA-UHFFFAOYSA-N 0.000 description 1
- FBPINGSGHKXIQA-UHFFFAOYSA-N 2-amino-3-(2-carboxyethylsulfanyl)propanoic acid Chemical compound OC(=O)C(N)CSCCC(O)=O FBPINGSGHKXIQA-UHFFFAOYSA-N 0.000 description 1
- YVQQHLHPYKSUCZ-UHFFFAOYSA-N 2-anthracen-1-yl-4-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC=C(C#N)C(C=2C3=CC4=CC=CC=C4C=C3C=CC=2)=C1 YVQQHLHPYKSUCZ-UHFFFAOYSA-N 0.000 description 1
- QMMGWAWSJVLSMC-UHFFFAOYSA-N 2-anthracen-1-yl-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC3=CC=CC=C3C=C2C=CC=1)OCC1=CC=CC=C1 QMMGWAWSJVLSMC-UHFFFAOYSA-N 0.000 description 1
- WEEDGGPLIRLXQL-UHFFFAOYSA-N 2-anthracen-1-yl-4-formylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C3=CC4=CC=CC=C4C=C3C=CC=2)=C1 WEEDGGPLIRLXQL-UHFFFAOYSA-N 0.000 description 1
- VWTUKRTYMDYCOD-UHFFFAOYSA-N 2-anthracen-9-yl-4-[hydroxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(O)C1=CC=C(C#N)C(C=2C3=CC=CC=C3C=C3C=CC=CC3=2)=C1 VWTUKRTYMDYCOD-UHFFFAOYSA-N 0.000 description 1
- YADINKDCZSDNAA-UHFFFAOYSA-N 2-anthracen-9-yl-4-formylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=C3C=CC=CC3=2)=C1 YADINKDCZSDNAA-UHFFFAOYSA-N 0.000 description 1
- QXISTPDUYKNPLU-UHFFFAOYSA-N 2-bromo-1,4-dimethylbenzene Chemical group CC1=CC=C(C)C(Br)=C1 QXISTPDUYKNPLU-UHFFFAOYSA-N 0.000 description 1
- FOVQCPSLQZIRSB-UHFFFAOYSA-N 2-bromo-4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C(Br)=C1 FOVQCPSLQZIRSB-UHFFFAOYSA-N 0.000 description 1
- VQVCDZDGPUOTHO-UHFFFAOYSA-N 2-bromo-4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(Br)=C1 VQVCDZDGPUOTHO-UHFFFAOYSA-N 0.000 description 1
- DIJITVIFBFXYRR-UHFFFAOYSA-N 2-bromo-4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(Br)=C1 DIJITVIFBFXYRR-UHFFFAOYSA-N 0.000 description 1
- UTYYRLJAFLKUTL-UHFFFAOYSA-N 2-bromo-4-formylbenzonitrile Chemical compound BrC1=CC(C=O)=CC=C1C#N UTYYRLJAFLKUTL-UHFFFAOYSA-N 0.000 description 1
- FKCZWNRLXIGZNK-UHFFFAOYSA-N 2-chloro-4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(Cl)=C1 FKCZWNRLXIGZNK-UHFFFAOYSA-N 0.000 description 1
- IBDXFTVHNUZFQB-UHFFFAOYSA-N 2-chloro-4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(Cl)=C1 IBDXFTVHNUZFQB-UHFFFAOYSA-N 0.000 description 1
- IEEOLVBCAVVKLO-UHFFFAOYSA-N 2-chloro-4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C#N)C(Cl)=C1 IEEOLVBCAVVKLO-UHFFFAOYSA-N 0.000 description 1
- GZELPDCDUYPUTD-UHFFFAOYSA-N 2-chloro-4-formylbenzonitrile Chemical compound ClC1=CC(C=O)=CC=C1C#N GZELPDCDUYPUTD-UHFFFAOYSA-N 0.000 description 1
- HLFNGYARDINCQT-UHFFFAOYSA-N 2-chloro-4-iodobenzonitrile Chemical compound ClC1=CC(I)=CC=C1C#N HLFNGYARDINCQT-UHFFFAOYSA-N 0.000 description 1
- MMCUPHGEJHPGHW-UHFFFAOYSA-N 2-chloro-n-[(4-cyano-3-naphthalen-1-ylphenyl)methyl]-n-(2-cyclohexylethyl)acetamide Chemical compound C=1C=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=CC=1CN(C(=O)CCl)CCC1CCCCC1 MMCUPHGEJHPGHW-UHFFFAOYSA-N 0.000 description 1
- OTZZKMMBXXDQIC-UHFFFAOYSA-N 2-cyclohexyl-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C1CCCCC1)OCC1=CC=CC=C1 OTZZKMMBXXDQIC-UHFFFAOYSA-N 0.000 description 1
- SQMHQFDDBRMSKI-UHFFFAOYSA-N 2-cyclohexyl-4-formylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C2CCCCC2)=C1 SQMHQFDDBRMSKI-UHFFFAOYSA-N 0.000 description 1
- ZQEXBVHABAJPHJ-UHFFFAOYSA-N 2-fluoro-4-methylaniline Chemical group CC1=CC=C(N)C(F)=C1 ZQEXBVHABAJPHJ-UHFFFAOYSA-N 0.000 description 1
- WCGNLBCJPBKXCN-UHFFFAOYSA-N 2-fluoro-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C(F)=C1 WCGNLBCJPBKXCN-UHFFFAOYSA-N 0.000 description 1
- AJTUKWIQLKKRHE-UHFFFAOYSA-N 2-iodo-4-methylaniline Chemical group CC1=CC=C(N)C(I)=C1 AJTUKWIQLKKRHE-UHFFFAOYSA-N 0.000 description 1
- UGBADSWJBWSKEE-UHFFFAOYSA-N 2-iodo-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C(I)=C1 UGBADSWJBWSKEE-UHFFFAOYSA-N 0.000 description 1
- HKUQGIRPFCHGLS-UHFFFAOYSA-N 2-isoquinolin-4-yl-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=NC=1)OCC1=CC=CC=C1 HKUQGIRPFCHGLS-UHFFFAOYSA-N 0.000 description 1
- UIJAUUZXOSTLOG-UHFFFAOYSA-N 2-isoquinolin-4-yl-4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]benzonitrile;dihydrochloride Chemical compound Cl.Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=NC=1)OCC1=CC=CC=C1 UIJAUUZXOSTLOG-UHFFFAOYSA-N 0.000 description 1
- CTTUUXGJIWMJHV-UHFFFAOYSA-N 2-methyl-6-phenylbenzonitrile Chemical compound CC1=CC=CC(C=2C=CC=CC=2)=C1C#N CTTUUXGJIWMJHV-UHFFFAOYSA-N 0.000 description 1
- TXTZFMIJGWCZFX-UHFFFAOYSA-N 2-methyl-6-phenylbenzonitrile hydrochloride Chemical compound Cl.CC1=C(C(=CC=C1)C1=CC=CC=C1)C#N TXTZFMIJGWCZFX-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- AJKWARQAJIPNBT-UHFFFAOYSA-N 2-naphthalen-1-yl-4-[[[4-(trifluoromethoxy)phenyl]methylamino]methyl]benzonitrile Chemical compound C1=CC(OC(F)(F)F)=CC=C1CNCC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 AJKWARQAJIPNBT-UHFFFAOYSA-N 0.000 description 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
- NVVDPZPZBPRJMY-UHFFFAOYSA-N 2-phenyl-6-(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC=CC=2)=C1C#N NVVDPZPZBPRJMY-UHFFFAOYSA-N 0.000 description 1
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 description 1
- XCGKVICEZQNWOF-UHFFFAOYSA-N 2-phenylbenzonitrile;hydrochloride Chemical compound Cl.N#CC1=CC=CC=C1C1=CC=CC=C1 XCGKVICEZQNWOF-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BKSTUBCLBUSJLX-UHFFFAOYSA-N 3,4-dichloro-n-[(4-cyano-3-naphthalen-1-ylphenyl)methyl]-n-[(3-methylimidazol-4-yl)methyl]benzamide Chemical compound CN1C=NC=C1CN(C(=O)C=1C=C(Cl)C(Cl)=CC=1)CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 BKSTUBCLBUSJLX-UHFFFAOYSA-N 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical group ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- KIXKOOUXCKDEOT-UHFFFAOYSA-N 3-(2-chlorophenyl)-4-methoxycarbonylbenzoic acid Chemical compound COC(=O)C1=CC=C(C(O)=O)C=C1C1=CC=CC=C1Cl KIXKOOUXCKDEOT-UHFFFAOYSA-N 0.000 description 1
- WVNBJBQNNBVFGV-UHFFFAOYSA-N 3-(2-methylphenyl)benzaldehyde Chemical compound CC1=CC=CC=C1C1=CC=CC(C=O)=C1 WVNBJBQNNBVFGV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- ZOWLLEBVXDSRDI-UHFFFAOYSA-N 3-(chloromethyl)-5-(2-methoxyphenyl)-1,2,4-oxadiazole Chemical group COC1=CC=CC=C1C1=NC(CCl)=NO1 ZOWLLEBVXDSRDI-UHFFFAOYSA-N 0.000 description 1
- GSWMZQIUADKXLN-UHFFFAOYSA-N 3-(chloromethyl)-5-(3-methoxyphenyl)-1,2,4-oxadiazole Chemical group COC1=CC=CC(C=2ON=C(CCl)N=2)=C1 GSWMZQIUADKXLN-UHFFFAOYSA-N 0.000 description 1
- LSYCZBSPYWGGHC-UHFFFAOYSA-N 3-(chloromethyl)-5-(4-methoxyphenyl)-1,2,4-oxadiazole Chemical group C1=CC(OC)=CC=C1C1=NC(CCl)=NO1 LSYCZBSPYWGGHC-UHFFFAOYSA-N 0.000 description 1
- INANILNLXTUPHD-UHFFFAOYSA-N 3-(chloromethyl)-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical group FC(F)(F)C1=CC=CC(C=2ON=C(CCl)N=2)=C1 INANILNLXTUPHD-UHFFFAOYSA-N 0.000 description 1
- IOVWIIJODVBCRC-UHFFFAOYSA-N 3-(chloromethyl)-5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical group C1=CC(C(F)(F)F)=CC=C1C1=NC(CCl)=NO1 IOVWIIJODVBCRC-UHFFFAOYSA-N 0.000 description 1
- VEIXFEJMHJPUBS-UHFFFAOYSA-N 3-(chloromethyl)-5-phenyl-1,2,4-oxadiazole Chemical group ClCC1=NOC(C=2C=CC=CC=2)=N1 VEIXFEJMHJPUBS-UHFFFAOYSA-N 0.000 description 1
- SADHVOSOZBAAGL-UHFFFAOYSA-N 3-(trifluoromethoxy)aniline Chemical compound NC1=CC=CC(OC(F)(F)F)=C1 SADHVOSOZBAAGL-UHFFFAOYSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- DMGFVJVLVZOSOE-UHFFFAOYSA-N 3-amino-4-chlorobenzoic acid Chemical compound NC1=CC(C(O)=O)=CC=C1Cl DMGFVJVLVZOSOE-UHFFFAOYSA-N 0.000 description 1
- GFWBKUDRXMQSFD-FJXQXJEOSA-M 3-aminopropanoyl-[(1s)-1-carboxy-2-(1h-imidazol-5-yl)ethyl]azanide;zinc Chemical compound [Zn].NCCC(=O)[N-][C@H](C(O)=O)CC1=CN=CN1 GFWBKUDRXMQSFD-FJXQXJEOSA-M 0.000 description 1
- AFWCFITYMGKIRT-UHFFFAOYSA-N 3-bromo-4-(2-cyanoethyl)benzoic acid Chemical group OC(=O)C1=CC=C(CCC#N)C(Br)=C1 AFWCFITYMGKIRT-UHFFFAOYSA-N 0.000 description 1
- SUISZCALMBHJQX-UHFFFAOYSA-N 3-bromobenzaldehyde Chemical group BrC1=CC=CC(C=O)=C1 SUISZCALMBHJQX-UHFFFAOYSA-N 0.000 description 1
- XCMISAPCWHTVNG-UHFFFAOYSA-N 3-bromothiophene Chemical compound BrC=1C=CSC=1 XCMISAPCWHTVNG-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- BNYKZFOZWZMEJD-UHFFFAOYSA-N 3-methylimidazole-4-carbaldehyde Chemical compound CN1C=NC=C1C=O BNYKZFOZWZMEJD-UHFFFAOYSA-N 0.000 description 1
- XNLWJFYYOIRPIO-UHFFFAOYSA-N 3-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1 XNLWJFYYOIRPIO-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NTRZRPOAPXVRSD-UHFFFAOYSA-N 4-(2-imidazol-1-yl-1-phenylmethoxyethyl)-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(CN2C=NC=C2)OCC=2C=CC=CC=2)=CC=C1C#N NTRZRPOAPXVRSD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- OINQGMKDDTUMEI-UHFFFAOYSA-N 4-(3-methylimidazole-4-carbonyl)-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(=O)C=2N(C=NC=2)C)=CC=C1C#N OINQGMKDDTUMEI-UHFFFAOYSA-N 0.000 description 1
- GMSYIDQWLRZYRN-UHFFFAOYSA-N 4-(3-methylimidazole-4-carbonyl)-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(=O)C=2N(C=NC=2)C)=CC=C1C#N GMSYIDQWLRZYRN-UHFFFAOYSA-N 0.000 description 1
- HOKYCSFEOCXZSE-UHFFFAOYSA-N 4-(3-methylimidazole-4-carbonyl)-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1C(=O)C1=CC=C(C#N)C(C=2C3=NC=CC=C3C=CC=2)=C1 HOKYCSFEOCXZSE-UHFFFAOYSA-N 0.000 description 1
- LFIWXXXFJFOECP-UHFFFAOYSA-N 4-(aminomethyl)benzonitrile Chemical compound NCC1=CC=C(C#N)C=C1 LFIWXXXFJFOECP-UHFFFAOYSA-N 0.000 description 1
- XLWSBDFQAJXCQX-UHFFFAOYSA-N 4-(bromomethyl)-1,2-dichlorobenzene Chemical group ClC1=CC=C(CBr)C=C1Cl XLWSBDFQAJXCQX-UHFFFAOYSA-N 0.000 description 1
- JJIFTOPVKWDHJI-UHFFFAOYSA-N 4-(bromomethyl)-1,2-difluorobenzene Chemical group FC1=CC=C(CBr)C=C1F JJIFTOPVKWDHJI-UHFFFAOYSA-N 0.000 description 1
- VXPPBTSPCBJJGO-UHFFFAOYSA-N 4-(bromomethyl)-6-methylbenzene-1,3-dicarbonitrile Chemical group CC1=CC(CBr)=C(C#N)C=C1C#N VXPPBTSPCBJJGO-UHFFFAOYSA-N 0.000 description 1
- UBQRAAXAHIKWRI-UHFFFAOYSA-N 4-(chloromethyl)-1,2-dimethylbenzene Chemical group CC1=CC=C(CCl)C=C1C UBQRAAXAHIKWRI-UHFFFAOYSA-N 0.000 description 1
- UEJQTBKTWJQBRN-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-chlorophenyl)-1,3-thiazole Chemical group ClCC1=CSC(C=2C=CC(Cl)=CC=2)=N1 UEJQTBKTWJQBRN-UHFFFAOYSA-N 0.000 description 1
- QOWNNZROJKFRSK-UHFFFAOYSA-N 4-(chloromethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical group C1=CC(C(F)(F)F)=CC=C1C1=NC(CCl)=CS1 QOWNNZROJKFRSK-UHFFFAOYSA-N 0.000 description 1
- RFGFQGPCVJEOBX-UHFFFAOYSA-N 4-(hydroxymethyl)-2-(2-propan-2-ylphenyl)benzonitrile Chemical compound CC(C)C1=CC=CC=C1C1=CC(CO)=CC=C1C#N RFGFQGPCVJEOBX-UHFFFAOYSA-N 0.000 description 1
- BQGJTJATNCAFPA-UHFFFAOYSA-N 4-(hydroxymethyl)-2-(5,6,7,8-tetrahydronaphthalen-1-yl)benzonitrile Chemical compound OCC1=CC=C(C#N)C(C=2C=3CCCCC=3C=CC=2)=C1 BQGJTJATNCAFPA-UHFFFAOYSA-N 0.000 description 1
- NTDQEOIMBBFSMJ-UHFFFAOYSA-N 4-(hydroxymethyl)-2-iodobenzonitrile Chemical compound OCC1=CC=C(C#N)C(I)=C1 NTDQEOIMBBFSMJ-UHFFFAOYSA-N 0.000 description 1
- DABRWURUJDQOGX-UHFFFAOYSA-N 4-(hydroxymethyl)-2-naphthalen-2-ylbenzonitrile Chemical compound OCC1=CC=C(C#N)C(C=2C=C3C=CC=CC3=CC=2)=C1 DABRWURUJDQOGX-UHFFFAOYSA-N 0.000 description 1
- LKTSJVBVDDIAJC-UHFFFAOYSA-N 4-(hydroxymethyl)-2-thiophen-3-ylbenzonitrile Chemical compound OCC1=CC=C(C#N)C(C2=CSC=C2)=C1 LKTSJVBVDDIAJC-UHFFFAOYSA-N 0.000 description 1
- GXYFRGKYSBWAEO-UHFFFAOYSA-N 4-(hydroxymethyl)-3-methyl-1h-imidazole-2-thione Chemical compound CN1C(CO)=CNC1=S GXYFRGKYSBWAEO-UHFFFAOYSA-N 0.000 description 1
- NZKAHCXIOQIGCS-UHFFFAOYSA-N 4-(sulfanylmethyl)benzonitrile Chemical compound SCC1=CC=C(C#N)C=C1 NZKAHCXIOQIGCS-UHFFFAOYSA-N 0.000 description 1
- SKLUWKYNZNXSLX-UHFFFAOYSA-N 4-Acetamidobenzaldehyde Chemical group CC(=O)NC1=CC=C(C=O)C=C1 SKLUWKYNZNXSLX-UHFFFAOYSA-N 0.000 description 1
- LAKNGHHYZLYNRX-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(Cl)=CC=2)Cl)C=2N(C=NC=2)C)=CC=C1C#N LAKNGHHYZLYNRX-UHFFFAOYSA-N 0.000 description 1
- FMAAXHVAMZHDSI-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(Cl)C=C1Cl FMAAXHVAMZHDSI-UHFFFAOYSA-N 0.000 description 1
- GLHLBOHPBUWTKG-UHFFFAOYSA-N 4-[(2,5-difluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=C(F)C=2)F)C=2N(C=NC=2)C)=CC=C1C#N GLHLBOHPBUWTKG-UHFFFAOYSA-N 0.000 description 1
- PBFAGUJEQXCLQS-UHFFFAOYSA-N 4-[(2,6-dichloropyridin-4-yl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC(Cl)=NC(Cl)=C1 PBFAGUJEQXCLQS-UHFFFAOYSA-N 0.000 description 1
- CFDRBHSLOFXPDE-UHFFFAOYSA-N 4-[(2-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=CC=2)C#N)C=2N(C=NC=2)C)=CC=C1C#N CFDRBHSLOFXPDE-UHFFFAOYSA-N 0.000 description 1
- RLIIWRZWVOMLOW-UHFFFAOYSA-N 4-[(2-fluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=CC=2)F)C=2N(C=NC=2)C)=CC=C1C#N RLIIWRZWVOMLOW-UHFFFAOYSA-N 0.000 description 1
- LCZJFBWLLWMUBK-UHFFFAOYSA-N 4-[(2-methoxy-5-nitrophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound COC1=CC=C([N+]([O-])=O)C=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C LCZJFBWLLWMUBK-UHFFFAOYSA-N 0.000 description 1
- RTCQVNQYQCERPG-UHFFFAOYSA-N 4-[(2-methoxy-5-nitrophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound COC1=CC=C([N+]([O-])=O)C=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C RTCQVNQYQCERPG-UHFFFAOYSA-N 0.000 description 1
- NJGBEKKDBCRCCD-UHFFFAOYSA-N 4-[(2-methoxy-5-nitrophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.COC1=CC=C([N+]([O-])=O)C=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C NJGBEKKDBCRCCD-UHFFFAOYSA-N 0.000 description 1
- UHRAFDSLBQHPNH-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-[2-(trifluoromethyl)phenyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C(F)(F)F)OCC1=CC=C(Cl)C(Cl)=C1 UHRAFDSLBQHPNH-UHFFFAOYSA-N 0.000 description 1
- JKAUXQZTUXDYCF-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(Cl)C(Cl)=C1 JKAUXQZTUXDYCF-UHFFFAOYSA-N 0.000 description 1
- HPFDGSJHZXZMLW-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(F)C(F)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N HPFDGSJHZXZMLW-UHFFFAOYSA-N 0.000 description 1
- HQSAIHDEGWYISD-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2C=C(F)C(F)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N HQSAIHDEGWYISD-UHFFFAOYSA-N 0.000 description 1
- GPHUMOYIUXTOSB-UHFFFAOYSA-N 4-[(3,4-dimethylphenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound C1=C(C)C(C)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C GPHUMOYIUXTOSB-UHFFFAOYSA-N 0.000 description 1
- YUMONLILFWGPTJ-UHFFFAOYSA-N 4-[(3,5-difluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(F)C=C(F)C=2)C=2N(C=NC=2)C)=CC=C1C#N YUMONLILFWGPTJ-UHFFFAOYSA-N 0.000 description 1
- GPMDCPXRMKPWIL-UHFFFAOYSA-N 4-[(3-chlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(Cl)C=CC=2)C=2N(C=NC=2)C)=CC=C1C#N GPMDCPXRMKPWIL-UHFFFAOYSA-N 0.000 description 1
- BJGDNQDLAYTFDT-UHFFFAOYSA-N 4-[(3-chlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC(Cl)=C1 BJGDNQDLAYTFDT-UHFFFAOYSA-N 0.000 description 1
- UECDXBYNFSLTKG-UHFFFAOYSA-N 4-[(3-chlorophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=CC(Cl)=C1 UECDXBYNFSLTKG-UHFFFAOYSA-N 0.000 description 1
- HMLRASHWZQVMOZ-UHFFFAOYSA-N 4-[(3-cyanoanilino)-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NC1=CC=CC(C#N)=C1 HMLRASHWZQVMOZ-UHFFFAOYSA-N 0.000 description 1
- IGATXPCFVXOZFI-UHFFFAOYSA-N 4-[(3-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(C=CC=2)C#N)C=2N(C=NC=2)C)=CC=C1C#N IGATXPCFVXOZFI-UHFFFAOYSA-N 0.000 description 1
- KCSDNMBZSOVJEZ-UHFFFAOYSA-N 4-[(3-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC(C#N)=C1 KCSDNMBZSOVJEZ-UHFFFAOYSA-N 0.000 description 1
- DHZKPYBJOKIQKB-UHFFFAOYSA-N 4-[(3-cyanophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(N(CC=2N(C=NC=2)C)CC=2C=C(C=CC=2)C#N)=CC=C1C#N DHZKPYBJOKIQKB-UHFFFAOYSA-N 0.000 description 1
- IQZCODLAPFPVNS-UHFFFAOYSA-N 4-[(3-cyanophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=CC(C#N)=C1 IQZCODLAPFPVNS-UHFFFAOYSA-N 0.000 description 1
- NZLTYOOHOYIKOG-UHFFFAOYSA-N 4-[(3-fluorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(F)C=CC=2)C=2N(C=NC=2)C)=CC=C1C#N NZLTYOOHOYIKOG-UHFFFAOYSA-N 0.000 description 1
- LFFSUIJNFZPRED-UHFFFAOYSA-N 4-[(3-iodophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(I)C=CC=2)C=2N(C=NC=2)C)=CC=C1C#N LFFSUIJNFZPRED-UHFFFAOYSA-N 0.000 description 1
- HBWBSLUINYWXEA-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-(2-phenylethylamino)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCCC1=CC=CC=C1 HBWBSLUINYWXEA-UHFFFAOYSA-N 0.000 description 1
- UUHYTJOZNUHCNO-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-(quinolin-8-ylmethoxy)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C3=NC=CC=C3C=CC=2)C=2N(C=NC=2)C)=CC=C1C#N UUHYTJOZNUHCNO-UHFFFAOYSA-N 0.000 description 1
- HYGDGTQWDSTSLS-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(1-methyl-2-oxopyridin-4-yl)methylamino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC(=O)N(C)C=C1 HYGDGTQWDSTSLS-UHFFFAOYSA-N 0.000 description 1
- OSUJGMDXLAQUFC-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(2-methylphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C OSUJGMDXLAQUFC-UHFFFAOYSA-N 0.000 description 1
- WNAHDNSGJRGKHV-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(2-nitrophenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=CC=2)[N+]([O-])=O)C=2N(C=NC=2)C)=CC=C1C#N WNAHDNSGJRGKHV-UHFFFAOYSA-N 0.000 description 1
- ASDNIRVTGYTBTH-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(2-nitrophenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=CC=2)[N+]([O-])=O)C=2N(C=NC=2)C)=CC=C1C#N ASDNIRVTGYTBTH-UHFFFAOYSA-N 0.000 description 1
- HNUAERJMOKMUBM-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(3,4,5-trimethoxyphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound COC1=C(OC)C(OC)=CC(COC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=C1 HNUAERJMOKMUBM-UHFFFAOYSA-N 0.000 description 1
- BGNYWTDEPXUKKR-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(3,4,5-trimethoxyphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(COC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=C1 BGNYWTDEPXUKKR-UHFFFAOYSA-N 0.000 description 1
- BJIMRGCQMZVZHU-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(3-methylphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC(COC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=C1 BJIMRGCQMZVZHU-UHFFFAOYSA-N 0.000 description 1
- NAOHZCQLUAMWSL-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-methylsulfonylphenyl)methylamino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(S(C)(=O)=O)C=C1 NAOHZCQLUAMWSL-UHFFFAOYSA-N 0.000 description 1
- RCINQVGGOPIMBH-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-nitrophenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(=CC=2)[N+]([O-])=O)C=2N(C=NC=2)C)=CC=C1C#N RCINQVGGOPIMBH-UHFFFAOYSA-N 0.000 description 1
- PPQCGIHQLWJKEI-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-nitrophenyl)methoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C([N+]([O-])=O)C=C1 PPQCGIHQLWJKEI-UHFFFAOYSA-N 0.000 description 1
- XFCCTDLVQQXQTB-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-phenylmethoxyphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(OCC=3C=CC=CC=3)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N XFCCTDLVQQXQTB-UHFFFAOYSA-N 0.000 description 1
- JLQFXAIOFXEXRU-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[(4-phenylphenyl)methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(=CC=2)C=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N JLQFXAIOFXEXRU-UHFFFAOYSA-N 0.000 description 1
- JRGMLGQTPSFHEH-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2N=C(SC=2)C=2C=CC(=CC=2)C(F)(F)F)C=2N(C=NC=2)C)=CC=C1C#N JRGMLGQTPSFHEH-UHFFFAOYSA-N 0.000 description 1
- HGMDIDCBRYDRLI-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[3-(trifluoromethoxy)phenyl]methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(OC(F)(F)F)C=CC=2)C=2N(C=NC=2)C)=CC=C1C#N HGMDIDCBRYDRLI-UHFFFAOYSA-N 0.000 description 1
- MLJYSPZUWPQJRS-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[3-(trifluoromethyl)phenyl]methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(C=CC=2)C(F)(F)F)C=2N(C=NC=2)C)=CC=C1C#N MLJYSPZUWPQJRS-UHFFFAOYSA-N 0.000 description 1
- VFFAFHZIAQVLSO-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[3-(trifluoromethyl)phenyl]methoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC(C(F)(F)F)=C1 VFFAFHZIAQVLSO-UHFFFAOYSA-N 0.000 description 1
- NUYKOWNUSXIDGH-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[4-(trifluoromethoxy)phenyl]methoxy]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(OC(F)(F)F)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N NUYKOWNUSXIDGH-UHFFFAOYSA-N 0.000 description 1
- ZHKBAJGFVOEMSM-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[4-(trifluoromethoxy)phenyl]methoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(OC(F)(F)F)C=C1 ZHKBAJGFVOEMSM-UHFFFAOYSA-N 0.000 description 1
- BELYHWKBXNRSBK-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[4-(trifluoromethoxy)phenyl]methoxy]methyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(OC(F)(F)F)C=C1 BELYHWKBXNRSBK-UHFFFAOYSA-N 0.000 description 1
- OBLIWYTWLDEBID-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[4-(trifluoromethyl)phenyl]methoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C(F)(F)F)C=C1 OBLIWYTWLDEBID-UHFFFAOYSA-N 0.000 description 1
- NVCCZOFUSYCBQJ-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-[[5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methoxy]methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2N=C(ON=2)C=2C=C(C=CC=2)C(F)(F)F)C=2N(C=NC=2)C)=CC=C1C#N NVCCZOFUSYCBQJ-UHFFFAOYSA-N 0.000 description 1
- KJUACXGHLNSAHL-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(2-methylnaphthalen-1-yl)benzonitrile Chemical compound CC1=CC=C2C=CC=CC2=C1C(C(=CC=1)C#N)=CC=1C(C=1N(C=NC=1)C)OCC1=CC=CC=C1 KJUACXGHLNSAHL-UHFFFAOYSA-N 0.000 description 1
- SQGUKKCKHPXDCI-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(2-methylnaphthalen-1-yl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=C2C=CC=CC2=C1C(C(=CC=1)C#N)=CC=1C(C=1N(C=NC=1)C)OCC1=CC=CC=C1 SQGUKKCKHPXDCI-UHFFFAOYSA-N 0.000 description 1
- WNWCSJWUFYSYRF-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N WNWCSJWUFYSYRF-UHFFFAOYSA-N 0.000 description 1
- LPMWPJNZFFPELH-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N LPMWPJNZFFPELH-UHFFFAOYSA-N 0.000 description 1
- NXOKGYLAYNRHCN-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(2-phenylphenyl)benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C=1C=CC=CC=1)OCC1=CC=CC=C1 NXOKGYLAYNRHCN-UHFFFAOYSA-N 0.000 description 1
- DQORMKKACKNQQY-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(3-methylphenyl)benzonitrile Chemical compound CC1=CC=CC(C=2C(=CC=C(C=2)C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)C#N)=C1 DQORMKKACKNQQY-UHFFFAOYSA-N 0.000 description 1
- RLNGVMKAQUJLEK-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(3-phenylphenyl)benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C=C(C=CC=1)C=1C=CC=CC=1)OCC1=CC=CC=C1 RLNGVMKAQUJLEK-UHFFFAOYSA-N 0.000 description 1
- IVRMLMROFULGQX-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-(4-methylphenyl)benzonitrile Chemical compound C1=CC(C)=CC=C1C1=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N IVRMLMROFULGQX-UHFFFAOYSA-N 0.000 description 1
- SUUNTBURAYUVSO-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC=C1 SUUNTBURAYUVSO-UHFFFAOYSA-N 0.000 description 1
- GVLODGGHYSJXGV-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC=C1 GVLODGGHYSJXGV-UHFFFAOYSA-N 0.000 description 1
- ROBYHTANPGNBCW-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-naphthalen-2-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C=C2C=CC=CC2=CC=1)OCC1=CC=CC=C1 ROBYHTANPGNBCW-UHFFFAOYSA-N 0.000 description 1
- XHVSRKFNRMCKDZ-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-naphthalen-2-ylbenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C=C2C=CC=CC2=CC=1)OCC1=CC=CC=C1 XHVSRKFNRMCKDZ-UHFFFAOYSA-N 0.000 description 1
- ZLHNKLZZRVTWDV-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-thiophen-3-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C1=CSC=C1)OCC1=CC=CC=C1 ZLHNKLZZRVTWDV-UHFFFAOYSA-N 0.000 description 1
- AZRJRXLKQPGLCV-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)-phenylmethoxymethyl]-2-thiophen-3-ylbenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C1=CSC=C1)OCC1=CC=CC=C1 AZRJRXLKQPGLCV-UHFFFAOYSA-N 0.000 description 1
- SNIWQLOCIIZGJA-UHFFFAOYSA-N 4-[(3-methylimidazol-4-yl)methylamino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CNC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 SNIWQLOCIIZGJA-UHFFFAOYSA-N 0.000 description 1
- CVZSTNANRLRUAO-UHFFFAOYSA-N 4-[(4-bromophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(Br)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N CVZSTNANRLRUAO-UHFFFAOYSA-N 0.000 description 1
- KJPLDKKMXQNJQG-UHFFFAOYSA-N 4-[(4-bromophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(Br)C=C1 KJPLDKKMXQNJQG-UHFFFAOYSA-N 0.000 description 1
- JHBQWSDQIPGQAW-UHFFFAOYSA-N 4-[(4-chloro-2-nitrophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(Cl)=CC=2)[N+]([O-])=O)C=2N(C=NC=2)C)=CC=C1C#N JHBQWSDQIPGQAW-UHFFFAOYSA-N 0.000 description 1
- PQXNLUZAJJXKFM-UHFFFAOYSA-N 4-[(4-chlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(Cl)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N PQXNLUZAJJXKFM-UHFFFAOYSA-N 0.000 description 1
- GJPCZIATKQWFDU-UHFFFAOYSA-N 4-[(4-chlorophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(Cl)C=C1 GJPCZIATKQWFDU-UHFFFAOYSA-N 0.000 description 1
- RMXTUGBGZLZKRQ-UHFFFAOYSA-N 4-[(4-cyanoanilino)-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NC1=CC=C(C#N)C=C1 RMXTUGBGZLZKRQ-UHFFFAOYSA-N 0.000 description 1
- XRIZGBFQCFMKKZ-UHFFFAOYSA-N 4-[(4-cyanophenoxy)-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OC1=CC=C(C#N)C=C1 XRIZGBFQCFMKKZ-UHFFFAOYSA-N 0.000 description 1
- MIARIKUHXQOGJS-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(1,3-thiazol-5-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CS1 MIARIKUHXQOGJS-UHFFFAOYSA-N 0.000 description 1
- OJUAVGSWRVSIPO-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(1-tritylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C=N1 OJUAVGSWRVSIPO-UHFFFAOYSA-N 0.000 description 1
- YPRGPOFXRODDSL-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(1h-imidazol-5-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1 YPRGPOFXRODDSL-UHFFFAOYSA-N 0.000 description 1
- MIXQQSGKQPRTOZ-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(1h-imidazol-5-yl)methyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.C1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1 MIXQQSGKQPRTOZ-UHFFFAOYSA-N 0.000 description 1
- WDRQPZYKUXVXMT-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2,3-dichlorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=C(Cl)C=CC=1)Cl)OCC1=CC=C(C#N)C=C1 WDRQPZYKUXVXMT-UHFFFAOYSA-N 0.000 description 1
- MHNLZNAHRFCLMU-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2,3-dimethylphenyl)benzonitrile Chemical compound CC1=CC=CC(C=2C(=CC=C(C=2)C(OCC=2C=CC(=CC=2)C#N)C=2N(C=NC=2)C)C#N)=C1C MHNLZNAHRFCLMU-UHFFFAOYSA-N 0.000 description 1
- PSLCBYNYWOWMGL-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2,4-dichlorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC(Cl)=CC=1)Cl)OCC1=CC=C(C#N)C=C1 PSLCBYNYWOWMGL-UHFFFAOYSA-N 0.000 description 1
- NSEVAJAIYPKQON-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-formylphenyl)benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C=O)OCC1=CC=C(C#N)C=C1 NSEVAJAIYPKQON-UHFFFAOYSA-N 0.000 description 1
- GZLGCYSBOHBCCK-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-[2-(hydroxymethyl)phenyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)CO)OCC1=CC=C(C#N)C=C1 GZLGCYSBOHBCCK-UHFFFAOYSA-N 0.000 description 1
- OVHHNUWVHOKUKE-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-[2-(trifluoromethyl)phenyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C(F)(F)F)OCC1=CC=C(C#N)C=C1 OVHHNUWVHOKUKE-UHFFFAOYSA-N 0.000 description 1
- KDYXMSMAYPFQTR-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-iodobenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(I)C(C#N)=CC=1)OCC1=CC=C(C#N)C=C1 KDYXMSMAYPFQTR-UHFFFAOYSA-N 0.000 description 1
- VDCZGNAVMDLMQS-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-iodobenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(I)C(C#N)=CC=1)OCC1=CC=C(C#N)C=C1 VDCZGNAVMDLMQS-UHFFFAOYSA-N 0.000 description 1
- ZBRVJLSHNVWEKS-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=C1 ZBRVJLSHNVWEKS-UHFFFAOYSA-N 0.000 description 1
- HYNIVCRZOIXWON-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-4-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2N=CC=1)OCC1=CC=C(C#N)C=C1 HYNIVCRZOIXWON-UHFFFAOYSA-N 0.000 description 1
- MCHBFAPRLAEBTN-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-5-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CN=C2C=CC=1)OCC1=CC=C(C#N)C=C1 MCHBFAPRLAEBTN-UHFFFAOYSA-N 0.000 description 1
- JEBWMRKLMHENFE-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-[3-(3-hydroxypropyl)imidazol-4-yl]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound OCCCN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=C1 JEBWMRKLMHENFE-UHFFFAOYSA-N 0.000 description 1
- CAXJFBOBWFOQIA-UHFFFAOYSA-N 4-[(4-cyanophenyl)methoxy-[3-(ethoxymethyl)imidazol-4-yl]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CCOCN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=C1 CAXJFBOBWFOQIA-UHFFFAOYSA-N 0.000 description 1
- RVXPVQXGMBCWPD-UHFFFAOYSA-N 4-[(4-cyanophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 RVXPVQXGMBCWPD-UHFFFAOYSA-N 0.000 description 1
- NGFACKQJBREMNJ-UHFFFAOYSA-N 4-[(4-cyanophenyl)methylsulfanyl-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)SCC1=CC=C(C#N)C=C1 NGFACKQJBREMNJ-UHFFFAOYSA-N 0.000 description 1
- ANPQYFXOVGFFJS-UHFFFAOYSA-N 4-[(4-cyanophenyl)methylsulfonyl-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(S(=O)(=O)CC=1C=CC(=CC=1)C#N)C1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 ANPQYFXOVGFFJS-UHFFFAOYSA-N 0.000 description 1
- OGNVFCQJIFXILQ-UHFFFAOYSA-N 4-[(4-iodophenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(I)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N OGNVFCQJIFXILQ-UHFFFAOYSA-N 0.000 description 1
- WHFYZZVSYIZSOE-UHFFFAOYSA-N 4-[(4-tert-butylphenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(=CC=2)C(C)(C)C)C=2N(C=NC=2)C)=CC=C1C#N WHFYZZVSYIZSOE-UHFFFAOYSA-N 0.000 description 1
- JYVFPMKYOGSQMC-UHFFFAOYSA-N 4-[(5,6-dichloropyridin-3-yl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=C(Cl)C(Cl)=NC=2)C=2N(C=NC=2)C)=CC=C1C#N JYVFPMKYOGSQMC-UHFFFAOYSA-N 0.000 description 1
- ZEWMFTSFLUWKNH-UHFFFAOYSA-N 4-[(5-acetyl-2-methoxyphenyl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound COC1=CC=C(C(C)=O)C=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C ZEWMFTSFLUWKNH-UHFFFAOYSA-N 0.000 description 1
- JETKYGRRYVOGJL-UHFFFAOYSA-N 4-[(6-chloro-1,3-benzodioxol-5-yl)methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC=3OCOC=3C=2)Cl)C=2N(C=NC=2)C)=CC=C1C#N JETKYGRRYVOGJL-UHFFFAOYSA-N 0.000 description 1
- RUWUHLDQPJFULA-UHFFFAOYSA-N 4-[(benzylamino)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CNCC=2C=CC=CC=2)=CC=C1C#N RUWUHLDQPJFULA-UHFFFAOYSA-N 0.000 description 1
- NAGFRLPNQVDBEU-UHFFFAOYSA-N 4-[(cyclohexylmethylamino)-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(NCC2CCCCC2)C=2N(C=NC=2)C)=CC=C1C#N NAGFRLPNQVDBEU-UHFFFAOYSA-N 0.000 description 1
- GTURWVWPNOUBNH-UHFFFAOYSA-N 4-[1-hydroxy-1-(3-methylimidazol-4-yl)-3-phenylprop-2-ynyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C#CC1=CC=CC=C1 GTURWVWPNOUBNH-UHFFFAOYSA-N 0.000 description 1
- MHXDXKYTQFUBGA-UHFFFAOYSA-N 4-[[(1-benzoylpiperidin-4-yl)amino]-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(NC2CCN(CC2)C(=O)C=2C=CC=CC=2)C=2N(C=NC=2)C)=CC=C1C#N MHXDXKYTQFUBGA-UHFFFAOYSA-N 0.000 description 1
- PBSIAWQCWQMXJG-UHFFFAOYSA-N 4-[[(1-benzoylpiperidin-4-yl)amino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NC1CCN(C(=O)C=2C=CC=CC=2)CC1 PBSIAWQCWQMXJG-UHFFFAOYSA-N 0.000 description 1
- QESJHPSVTUIALE-UHFFFAOYSA-N 4-[[(1-benzylpiperidin-4-yl)amino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NC1CCN(CC=2C=CC=CC=2)CC1 QESJHPSVTUIALE-UHFFFAOYSA-N 0.000 description 1
- GIRYXQYUGPYLIU-UHFFFAOYSA-N 4-[[(3,4-dichlorophenyl)methylamino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(Cl)C(Cl)=C1 GIRYXQYUGPYLIU-UHFFFAOYSA-N 0.000 description 1
- IVRFSWURNSQWJF-UHFFFAOYSA-N 4-[[(3-methylimidazol-4-yl)-phenylmethoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC=CC=1)OCC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 IVRFSWURNSQWJF-UHFFFAOYSA-N 0.000 description 1
- UVXWXLPXTQQKBT-UHFFFAOYSA-N 4-[[(3-methylimidazol-4-yl)methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C(F)(F)F)C=C1 UVXWXLPXTQQKBT-UHFFFAOYSA-N 0.000 description 1
- YKGSZDYCMHSFFQ-UHFFFAOYSA-N 4-[[(4-chlorophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(Cl)C=C1 YKGSZDYCMHSFFQ-UHFFFAOYSA-N 0.000 description 1
- QNYSTWZCYDSJIE-UHFFFAOYSA-N 4-[[(4-chlorophenyl)methylamino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(Cl)C=C1 QNYSTWZCYDSJIE-UHFFFAOYSA-N 0.000 description 1
- BCHFIQXDVPWFMC-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-2-fluorobenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(F)=C1 BCHFIQXDVPWFMC-UHFFFAOYSA-N 0.000 description 1
- ZZSGSRYVYRAVAH-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-2-iodobenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(I)=C1 ZZSGSRYVYRAVAH-UHFFFAOYSA-N 0.000 description 1
- XRBBGCLSXFRLSF-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-2-iodobenzonitrile;hydrochloride Chemical compound Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C(I)=C1 XRBBGCLSXFRLSF-UHFFFAOYSA-N 0.000 description 1
- RGKXCCYKPJKIOA-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C RGKXCCYKPJKIOA-UHFFFAOYSA-N 0.000 description 1
- CTZPTIYRUOPIQJ-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoic acid Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C(O)=O)C=C1 CTZPTIYRUOPIQJ-UHFFFAOYSA-N 0.000 description 1
- CHRVJDIMUUWKLG-UHFFFAOYSA-N 4-[[(4-cyano-3-naphthalen-1-ylphenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]benzoic acid Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C(O)=O)C=C1 CHRVJDIMUUWKLG-UHFFFAOYSA-N 0.000 description 1
- RUUOYMAETYNWRV-UHFFFAOYSA-N 4-[[(4-cyano-3-quinolin-8-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoic acid Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(C(O)=O)C=C1 RUUOYMAETYNWRV-UHFFFAOYSA-N 0.000 description 1
- LIQZKOSKKTXWLW-UHFFFAOYSA-N 4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)NC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 LIQZKOSKKTXWLW-UHFFFAOYSA-N 0.000 description 1
- GMQFNFKTMATOGW-UHFFFAOYSA-N 4-[[(4-cyanophenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 GMQFNFKTMATOGW-UHFFFAOYSA-N 0.000 description 1
- WPFBHRKQMSTRAR-UHFFFAOYSA-N 4-[[(4-cyanophenyl)methylamino]-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(NCC=2C=CC(=CC=2)C#N)C=2N(C=NC=2)C)=CC=C1C#N WPFBHRKQMSTRAR-UHFFFAOYSA-N 0.000 description 1
- TYLVCIRZNAIIFN-UHFFFAOYSA-N 4-[[(4-cyanophenyl)methylamino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C#N)C=C1 TYLVCIRZNAIIFN-UHFFFAOYSA-N 0.000 description 1
- LVHKCKONTKSTOG-UHFFFAOYSA-N 4-[[(4-cyanophenyl)methylamino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1CNCC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 LVHKCKONTKSTOG-UHFFFAOYSA-N 0.000 description 1
- HONXPMBJEZZMQQ-UHFFFAOYSA-N 4-[[(4-fluoro-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(F)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=C1 HONXPMBJEZZMQQ-UHFFFAOYSA-N 0.000 description 1
- GZEBXRFVPDEPOB-UHFFFAOYSA-N 4-[[1-(3-methylimidazol-4-yl)-2-phenylethoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(OCC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=CC=C1 GZEBXRFVPDEPOB-UHFFFAOYSA-N 0.000 description 1
- ZPACRGRXXJXDQT-UHFFFAOYSA-N 4-[[1-(3-methylimidazol-4-yl)-3-phenylpropoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(OCC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CCC1=CC=CC=C1 ZPACRGRXXJXDQT-UHFFFAOYSA-N 0.000 description 1
- RICVNMIWQWPNIF-UHFFFAOYSA-N 4-[[1-(4-cyanophenyl)ethylamino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(C)NC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C RICVNMIWQWPNIF-UHFFFAOYSA-N 0.000 description 1
- AFACWXACSVYBRJ-UHFFFAOYSA-N 4-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2N=C(SC=2)C=2C=CC(Cl)=CC=2)C=2N(C=NC=2)C)=CC=C1C#N AFACWXACSVYBRJ-UHFFFAOYSA-N 0.000 description 1
- HOEDKGWKYAMNJU-UHFFFAOYSA-N 4-[[2-(4-cyanophenyl)-1-(3-methylimidazol-4-yl)ethoxy]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(OCC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 HOEDKGWKYAMNJU-UHFFFAOYSA-N 0.000 description 1
- HCKLFWITVIETFK-UHFFFAOYSA-N 4-[[2-cyclohexylethyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CN(CCC2CCCCC2)CC=2N(C=NC=2)C)=CC=C1C#N HCKLFWITVIETFK-UHFFFAOYSA-N 0.000 description 1
- WSEDKZQXRNSHNK-UHFFFAOYSA-N 4-[[2-cyclohexylethyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CCC1CCCCC1 WSEDKZQXRNSHNK-UHFFFAOYSA-N 0.000 description 1
- PWLPXWPHDRDOIC-UHFFFAOYSA-N 4-[[2-fluoro-4-(trifluoromethyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(=CC=2)C(F)(F)F)F)C=2N(C=NC=2)C)=CC=C1C#N PWLPXWPHDRDOIC-UHFFFAOYSA-N 0.000 description 1
- XHYIYDOSILSYHK-UHFFFAOYSA-N 4-[[3-(ethoxymethyl)imidazol-4-yl]-phenylmethoxymethyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CCOCN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC=C1 XHYIYDOSILSYHK-UHFFFAOYSA-N 0.000 description 1
- NXRBYSFHJILZMV-UHFFFAOYSA-N 4-[[3-(ethoxymethyl)imidazol-4-yl]-phenylmethoxymethyl]-2-naphthalen-1-ylbenzonitrile;hydrochloride Chemical compound Cl.CCOCN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=CC=C1 NXRBYSFHJILZMV-UHFFFAOYSA-N 0.000 description 1
- DOHPKGHDWFHUCS-UHFFFAOYSA-N 4-[[3-chloro-5-(trifluoromethyl)pyridin-2-yl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(=CN=2)C(F)(F)F)Cl)C=2N(C=NC=2)C)=CC=C1C#N DOHPKGHDWFHUCS-UHFFFAOYSA-N 0.000 description 1
- AVZGHTACARXTFP-UHFFFAOYSA-N 4-[[3-chloro-5-(trifluoromethyl)pyridin-2-yl]methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=NC=C(C(F)(F)F)C=C1Cl AVZGHTACARXTFP-UHFFFAOYSA-N 0.000 description 1
- JZXOSZQDYLXQBS-UHFFFAOYSA-N 4-[[3-fluoro-4-(trifluoromethyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(C(F)(F)F)C(F)=C1 JZXOSZQDYLXQBS-UHFFFAOYSA-N 0.000 description 1
- QZJPEKDFQJYVFZ-UHFFFAOYSA-N 4-[[4-(2-cyanophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(=CC=2)C=2C(=CC=CC=2)C#N)C=2N(C=NC=2)C)=CC=C1C#N QZJPEKDFQJYVFZ-UHFFFAOYSA-N 0.000 description 1
- DEHPEFKCPVFWNC-UHFFFAOYSA-N 4-[[4-cyano-n-[(3-methylimidazol-4-yl)methyl]-3-naphthalen-1-ylanilino]methyl]benzoic acid Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C(O)=O)C=C1 DEHPEFKCPVFWNC-UHFFFAOYSA-N 0.000 description 1
- MRXXCEZJICKWMS-UHFFFAOYSA-N 4-[[4-fluoro-2-(trifluoromethyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(F)=CC=2)C(F)(F)F)C=2N(C=NC=2)C)=CC=C1C#N MRXXCEZJICKWMS-UHFFFAOYSA-N 0.000 description 1
- AVDMCFABCAZSNU-UHFFFAOYSA-N 4-[[4-fluoro-2-(trifluoromethyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(F)=CC=2)C(F)(F)F)C=2N(C=NC=2)C)=CC=C1C#N AVDMCFABCAZSNU-UHFFFAOYSA-N 0.000 description 1
- DOYPWPPNZYLSCG-UHFFFAOYSA-N 4-[[4-fluoro-3-(trifluoromethyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(F)C(C(F)(F)F)=C1 DOYPWPPNZYLSCG-UHFFFAOYSA-N 0.000 description 1
- URVJQHRJQVSAIZ-UHFFFAOYSA-N 4-[[[(3-methylimidazol-4-yl)-phenylmethyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC=CC=1)NCC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 URVJQHRJQVSAIZ-UHFFFAOYSA-N 0.000 description 1
- VHCACCLEICWUJS-UHFFFAOYSA-N 4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]-2-iodobenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C#N)C(I)=C1 VHCACCLEICWUJS-UHFFFAOYSA-N 0.000 description 1
- PQCOFYBPYOSZSY-UHFFFAOYSA-N 4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]-2-iodobenzonitrile;dihydrochloride Chemical compound Cl.Cl.CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C#N)C(I)=C1 PQCOFYBPYOSZSY-UHFFFAOYSA-N 0.000 description 1
- UZZMZIPLGKNBMC-UHFFFAOYSA-N 4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1CNC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C UZZMZIPLGKNBMC-UHFFFAOYSA-N 0.000 description 1
- XXSMKTGPMVXOAA-UHFFFAOYSA-N 4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]benzamide Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C(N)=O)C=C1 XXSMKTGPMVXOAA-UHFFFAOYSA-N 0.000 description 1
- YWSHBUCMOOVNMD-UHFFFAOYSA-N 4-[[[2-(4-cyanophenyl)-1-(3-methylimidazol-4-yl)ethyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(NCC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 YWSHBUCMOOVNMD-UHFFFAOYSA-N 0.000 description 1
- AONFVEWUXOSXGG-UHFFFAOYSA-N 4-[[[2-hydroxy-5-(trifluoromethoxy)phenyl]methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C(=CC=C(OC(F)(F)F)C=1)O)CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 AONFVEWUXOSXGG-UHFFFAOYSA-N 0.000 description 1
- CWADQCWNICVLKP-UHFFFAOYSA-N 4-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]-6-methylbenzene-1,3-dicarbonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C(=CC(=C(C)C=2)C#N)C#N)C=2N(C=NC=2)C)=CC=C1C#N CWADQCWNICVLKP-UHFFFAOYSA-N 0.000 description 1
- LUMBJQMQOPHIPH-UHFFFAOYSA-N 4-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]-6-methylbenzene-1,3-dicarbonitrile;hydrochloride Chemical compound Cl.C1=C(C#N)C(C)=CC(COC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=C1C#N LUMBJQMQOPHIPH-UHFFFAOYSA-N 0.000 description 1
- PUNUCEOKTIPTTI-UHFFFAOYSA-N 4-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C PUNUCEOKTIPTTI-UHFFFAOYSA-N 0.000 description 1
- PPMFEYLCPMBGSQ-UHFFFAOYSA-N 4-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]benzoic acid Chemical compound CC1=CC=CC=C1C1=CC(C(OCC=2C=CC(=CC=2)C(O)=O)C=2N(C=NC=2)C)=CC=C1C#N PPMFEYLCPMBGSQ-UHFFFAOYSA-N 0.000 description 1
- UDXHKVITGBKSOC-UHFFFAOYSA-N 4-[[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methyl]amino]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CNC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=CC=C1C#N UDXHKVITGBKSOC-UHFFFAOYSA-N 0.000 description 1
- MTBFQKHHFMVXPY-UHFFFAOYSA-N 4-[[benzyl(pyridin-3-ylmethyl)amino]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CN(CC=2C=CC=CC=2)CC=2C=NC=CC=2)=CC=C1C#N MTBFQKHHFMVXPY-UHFFFAOYSA-N 0.000 description 1
- HLURYQMTGCZIRX-UHFFFAOYSA-N 4-[[benzyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(CN(CC=2N(C=NC=2)C)CC=2C=CC=CC=2)=CC=C1C#N HLURYQMTGCZIRX-UHFFFAOYSA-N 0.000 description 1
- LOFWPIGCUICPGH-UHFFFAOYSA-N 4-[[butyl-[(4-cyanophenyl)methyl]amino]-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound C=1N=CN(C)C=1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)N(CCCC)CC1=CC=C(C#N)C=C1 LOFWPIGCUICPGH-UHFFFAOYSA-N 0.000 description 1
- RCDNGBDAPKOSIG-UHFFFAOYSA-N 4-[[cyclohexylmethyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1CCCCC1 RCDNGBDAPKOSIG-UHFFFAOYSA-N 0.000 description 1
- PQAXFRITJNLLKU-UHFFFAOYSA-N 4-[[ethyl-[(4-nitrophenyl)methyl]amino]-(3-methylimidazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound C=1N=CN(C)C=1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)N(CC)CC1=CC=C([N+]([O-])=O)C=C1 PQAXFRITJNLLKU-UHFFFAOYSA-N 0.000 description 1
- FQZKZXLGKXKOQT-UHFFFAOYSA-N 4-[benzyl(1h-imidazol-5-ylmethyl)amino]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(N(CC=2NC=NC=2)CC=2C=CC=CC=2)=CC=C1C#N FQZKZXLGKXKOQT-UHFFFAOYSA-N 0.000 description 1
- VKHOIBMYGRINJA-UHFFFAOYSA-N 4-[benzyl(1h-imidazol-5-ylmethyl)amino]-2-naphthalen-1-ylbenzonitrile Chemical compound C1=C(C=2C3=CC=CC=C3C=CC=2)C(C#N)=CC=C1N(CC=1C=CC=CC=1)CC1=CN=CN1 VKHOIBMYGRINJA-UHFFFAOYSA-N 0.000 description 1
- RTVKDAXOIFZGKJ-UHFFFAOYSA-N 4-[benzyl(pyridin-3-ylmethyl)amino]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(N(CC=2C=CC=CC=2)CC=2C=NC=CC=2)=CC=C1C#N RTVKDAXOIFZGKJ-UHFFFAOYSA-N 0.000 description 1
- MEIORMXCPJHTLF-UHFFFAOYSA-N 4-[benzyl-[(3-methylimidazol-4-yl)methyl]amino]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(N(CC=2N(C=NC=2)C)CC=2C=CC=CC=2)=CC=C1C#N MEIORMXCPJHTLF-UHFFFAOYSA-N 0.000 description 1
- RAHJVTVWCZJSBE-UHFFFAOYSA-N 4-[benzyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=CC=C1 RAHJVTVWCZJSBE-UHFFFAOYSA-N 0.000 description 1
- FHCZUHRNBIZFQC-UHFFFAOYSA-N 4-[chloro-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(Cl)C1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 FHCZUHRNBIZFQC-UHFFFAOYSA-N 0.000 description 1
- GWRSNBTXILESBM-UHFFFAOYSA-N 4-[cyclohexylmethoxy-(3-methylimidazol-4-yl)methyl]-2-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1CCCCC1 GWRSNBTXILESBM-UHFFFAOYSA-N 0.000 description 1
- BNOMNBFDCBYPFY-UHFFFAOYSA-N 4-[hexyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound C=1C=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=CC=1N(CCCCCC)CC1=CN=CN1C BNOMNBFDCBYPFY-UHFFFAOYSA-N 0.000 description 1
- PAAOCOKOMCUOGT-UHFFFAOYSA-N 4-[hydroxy-(3-methyltriazol-4-yl)methyl]-2-(2-methylphenyl)benzonitrile Chemical compound CC1=CC=CC=C1C1=CC(C(O)C=2N(N=NC=2)C)=CC=C1C#N PAAOCOKOMCUOGT-UHFFFAOYSA-N 0.000 description 1
- IFNOMGKCZUCMJL-UHFFFAOYSA-N 4-[methyl-[(3-methylimidazol-4-yl)methyl]amino]-2-naphthalen-1-ylbenzonitrile Chemical compound C=1C=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=CC=1N(C)CC1=CN=CN1C IFNOMGKCZUCMJL-UHFFFAOYSA-N 0.000 description 1
- NLPHXWGWBKZSJC-UHFFFAOYSA-N 4-acetylbenzonitrile Chemical group CC(=O)C1=CC=C(C#N)C=C1 NLPHXWGWBKZSJC-UHFFFAOYSA-N 0.000 description 1
- ZFBKYGFPUCUYIF-UHFFFAOYSA-N 4-amino-2-chlorobenzonitrile Chemical group NC1=CC=C(C#N)C(Cl)=C1 ZFBKYGFPUCUYIF-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- OMPHLGROCARZOU-UHFFFAOYSA-N 4-chloro-1-(chloromethyl)-2-nitrobenzene Chemical group [O-][N+](=O)C1=CC(Cl)=CC=C1CCl OMPHLGROCARZOU-UHFFFAOYSA-N 0.000 description 1
- LWAZVLVHQQMWHX-UHFFFAOYSA-N 4-chloro-3-(2-methylphenyl)benzaldehyde Chemical compound CC1=CC=CC=C1C1=CC(C=O)=CC=C1Cl LWAZVLVHQQMWHX-UHFFFAOYSA-N 0.000 description 1
- HJNVFTVTOKEQDC-UHFFFAOYSA-N 4-chloro-3-iodo-n-methoxy-n-methylbenzamide Chemical compound CON(C)C(=O)C1=CC=C(Cl)C(I)=C1 HJNVFTVTOKEQDC-UHFFFAOYSA-N 0.000 description 1
- SDRURVZKYHGDAP-UHFFFAOYSA-N 4-chloro-3-iodobenzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C(I)=C1 SDRURVZKYHGDAP-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-HOSYLAQJSA-N 4-chlorobenzaldehyde Chemical group ClC1=CC=C([13CH]=O)C=C1 AVPYQKSLYISFPO-HOSYLAQJSA-N 0.000 description 1
- KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline Chemical compound C1=CC=C2C(Cl)=CC=NC2=C1 KNDOFJFSHZCKGT-UHFFFAOYSA-N 0.000 description 1
- YGDHGEVOVRVGHN-UHFFFAOYSA-N 4-cyano-n-[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]benzenesulfonamide Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NS(=O)(=O)C1=CC=C(C#N)C=C1 YGDHGEVOVRVGHN-UHFFFAOYSA-N 0.000 description 1
- AKJXFLFGECTHOL-UHFFFAOYSA-N 4-cyano-n-[(4-cyanophenyl)methyl]-n-[(3-methylimidazol-4-yl)methyl]-3-naphthalen-1-ylbenzamide Chemical compound CN1C=NC=C1CN(C(=O)C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 AKJXFLFGECTHOL-UHFFFAOYSA-N 0.000 description 1
- IBVBZSBKGASOIZ-UHFFFAOYSA-N 4-cyano-n-[(4-cyanophenyl)methyl]-n-[(3-methylimidazol-4-yl)methyl]-3-quinolin-8-ylbenzamide Chemical compound CN1C=NC=C1CN(C(=O)C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)CC1=CC=C(C#N)C=C1 IBVBZSBKGASOIZ-UHFFFAOYSA-N 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- ZNIUOSMFRHRHEO-UHFFFAOYSA-N 4-fluoro-3-naphthalen-1-ylbenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1C1=CC=CC2=CC=CC=C12 ZNIUOSMFRHRHEO-UHFFFAOYSA-N 0.000 description 1
- HREGBPIKEVSOGC-UHFFFAOYSA-N 4-formyl-2-(2-methylnaphthalen-1-yl)benzonitrile Chemical compound CC1=CC=C2C=CC=CC2=C1C1=CC(C=O)=CC=C1C#N HREGBPIKEVSOGC-UHFFFAOYSA-N 0.000 description 1
- QRCQIQDYLNONEL-UHFFFAOYSA-N 4-formyl-2-(3-methylphenyl)benzonitrile Chemical compound CC1=CC=CC(C=2C(=CC=C(C=O)C=2)C#N)=C1 QRCQIQDYLNONEL-UHFFFAOYSA-N 0.000 description 1
- XNWWMFSHJNYXPL-UHFFFAOYSA-N 4-formyl-2-(3-phenylphenyl)benzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C=C(C=CC=2)C=2C=CC=CC=2)=C1 XNWWMFSHJNYXPL-UHFFFAOYSA-N 0.000 description 1
- AYKLXYHQTZDKKI-UHFFFAOYSA-N 4-formyl-2-(5,6,7,8-tetrahydronaphthalen-1-yl)benzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C=3CCCCC=3C=CC=2)=C1 AYKLXYHQTZDKKI-UHFFFAOYSA-N 0.000 description 1
- MLOFRZPFEAIJJE-UHFFFAOYSA-N 4-formyl-2-isoquinolin-4-ylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=NC=2)=C1 MLOFRZPFEAIJJE-UHFFFAOYSA-N 0.000 description 1
- XYGRIJHZIRRBLN-UHFFFAOYSA-N 4-formyl-2-naphthalen-1-ylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 XYGRIJHZIRRBLN-UHFFFAOYSA-N 0.000 description 1
- YTDDYACTRMEWIF-UHFFFAOYSA-N 4-formyl-2-naphthalen-2-ylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C=C3C=CC=CC3=CC=2)=C1 YTDDYACTRMEWIF-UHFFFAOYSA-N 0.000 description 1
- VJRPBHKOFDBYPD-UHFFFAOYSA-N 4-formyl-2-quinolin-8-ylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C=2C3=NC=CC=C3C=CC=2)=C1 VJRPBHKOFDBYPD-UHFFFAOYSA-N 0.000 description 1
- LPTJWUYYSJVQQS-UHFFFAOYSA-N 4-formyl-2-thiophen-3-ylbenzonitrile Chemical compound O=CC1=CC=C(C#N)C(C2=CSC=C2)=C1 LPTJWUYYSJVQQS-UHFFFAOYSA-N 0.000 description 1
- DXJZJYPLPZEYBH-UHFFFAOYSA-N 4-iodo-1-tritylimidazole Chemical compound C1=NC(I)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 DXJZJYPLPZEYBH-UHFFFAOYSA-N 0.000 description 1
- STERKHRCDZPNRE-UHFFFAOYSA-N 4-iodoquinoline Chemical compound C1=CC=C2C(I)=CC=NC2=C1 STERKHRCDZPNRE-UHFFFAOYSA-N 0.000 description 1
- PSVPUHBSBYJSMQ-UHFFFAOYSA-N 4-methylsulfonylbenzaldehyde Chemical group CS(=O)(=O)C1=CC=C(C=O)C=C1 PSVPUHBSBYJSMQ-UHFFFAOYSA-N 0.000 description 1
- SODWJACROGQSMM-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalen-1-amine Chemical compound C1CCCC2=C1C=CC=C2N SODWJACROGQSMM-UHFFFAOYSA-N 0.000 description 1
- JYIRARCOQHBCIH-UHFFFAOYSA-N 5,6-dichloro-n-[(4-cyano-3-naphthalen-1-ylphenyl)methyl]-n-[(3-methylimidazol-4-yl)methyl]pyridine-3-carboxamide Chemical compound CN1C=NC=C1CN(C(=O)C=1C=C(Cl)C(Cl)=NC=1)CC1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 JYIRARCOQHBCIH-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- JZYRDUGVEQPQNG-UHFFFAOYSA-N 5-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-2-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)N=C1 JZYRDUGVEQPQNG-UHFFFAOYSA-N 0.000 description 1
- DTVYNUOOZIKEEX-UHFFFAOYSA-N 5-aminoisoquinoline Chemical group N1=CC=C2C(N)=CC=CC2=C1 DTVYNUOOZIKEEX-UHFFFAOYSA-N 0.000 description 1
- QALKJGMGKYKMKE-UHFFFAOYSA-N 5-bromo-1,2-dihydroacenaphthylene Chemical group C1CC2=CC=CC3=C2C1=CC=C3Br QALKJGMGKYKMKE-UHFFFAOYSA-N 0.000 description 1
- APJKOQPCHGXQBI-UHFFFAOYSA-N 5-chloro-6-(chloromethyl)-1,3-benzodioxole Chemical group C1=C(Cl)C(CCl)=CC2=C1OCO2 APJKOQPCHGXQBI-UHFFFAOYSA-N 0.000 description 1
- BHCMXJKPZOPRNN-UHFFFAOYSA-N 5-iodo-1h-imidazole Chemical compound IC1=CN=CN1 BHCMXJKPZOPRNN-UHFFFAOYSA-N 0.000 description 1
- AIVSLDAXUIRICJ-UHFFFAOYSA-N 5-tert-butyl-3-(chloromethyl)-1,2,4-oxadiazole Chemical group CC(C)(C)C1=NC(CCl)=NO1 AIVSLDAXUIRICJ-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- QWCGOMIAXFNYIV-UHFFFAOYSA-N 6-(bromomethyl)pyridine-3-carbonitrile Chemical compound BrCC1=CC=C(C#N)C=N1 QWCGOMIAXFNYIV-UHFFFAOYSA-N 0.000 description 1
- LDGMRIKSIPEOFA-UHFFFAOYSA-N 6-[[(4-cyano-3-naphthalen-1-ylphenyl)-(1,3-thiazol-5-yl)methoxy]methyl]pyridine-3-carbonitrile Chemical compound N1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CS1 LDGMRIKSIPEOFA-UHFFFAOYSA-N 0.000 description 1
- ACXPVQQIYOUAGF-UHFFFAOYSA-N 6-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=N1 ACXPVQQIYOUAGF-UHFFFAOYSA-N 0.000 description 1
- MPDRDUWMPMYNPF-UHFFFAOYSA-N 6-[[(4-cyano-3-naphthalen-1-ylphenyl)-pyridin-3-ylmethoxy]methyl]pyridine-3-carbonitrile Chemical compound N1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CC=CN=C1 MPDRDUWMPMYNPF-UHFFFAOYSA-N 0.000 description 1
- NTEUVXGVLWCOJK-UHFFFAOYSA-N 6-[[(4-cyano-3-naphthalen-1-ylphenyl)-thiophen-3-ylmethoxy]methyl]pyridine-3-carbonitrile Chemical compound N1=CC(C#N)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CSC=C1 NTEUVXGVLWCOJK-UHFFFAOYSA-N 0.000 description 1
- HSUAOJAZANMDAQ-UHFFFAOYSA-N 6-[[(4-cyano-3-quinolin-8-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(C#N)C=N1 HSUAOJAZANMDAQ-UHFFFAOYSA-N 0.000 description 1
- UKABSCXWKMYFBW-UHFFFAOYSA-N 6-[[(4-cyano-3-quinolin-8-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carboxylic acid Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=NC=CC=C2C=CC=1)OCC1=CC=C(C(O)=O)C=N1 UKABSCXWKMYFBW-UHFFFAOYSA-N 0.000 description 1
- ACBRABHOCZMQRW-UHFFFAOYSA-N 6-[[[4-cyano-3-(2,3-dichlorophenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=C(Cl)C=CC=1)Cl)OCC1=CC=C(C#N)C=N1 ACBRABHOCZMQRW-UHFFFAOYSA-N 0.000 description 1
- BOUONYWLQUVBCX-UHFFFAOYSA-N 6-[[[4-cyano-3-[2-(trifluoromethyl)phenyl]phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C(F)(F)F)OCC1=CC=C(C#N)C=N1 BOUONYWLQUVBCX-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- UNQYAAAWKOOBFQ-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-8-[4-chloro-3-(trifluoromethoxy)phenoxy]-1-(3-hydroxypropyl)-3-methylpurine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=C(Cl)C(OC(F)(F)F)=C1 UNQYAAAWKOOBFQ-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- PSVFVAYNOKLOMR-UHFFFAOYSA-N 8-(chloromethyl)-6-nitro-4h-1,3-benzodioxine Chemical group O1COCC2=CC([N+](=O)[O-])=CC(CCl)=C21 PSVFVAYNOKLOMR-UHFFFAOYSA-N 0.000 description 1
- BKDZLPUEWDNSGH-UHFFFAOYSA-N 8-(chloromethyl)quinoline Chemical group C1=CN=C2C(CCl)=CC=CC2=C1 BKDZLPUEWDNSGH-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ZIRVQSRSPDUEOJ-UHFFFAOYSA-N 9-bromoanthracene Chemical group C1=CC=C2C(Br)=C(C=CC=C3)C3=CC2=C1 ZIRVQSRSPDUEOJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000012936 Angiostatins Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- PXKAGPRBYRFSTO-UHFFFAOYSA-N CC1=CC=CC=C1C1=CC=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=C1 Chemical compound CC1=CC=CC=C1C1=CC=CC(C(OCC=2C=CC=CC=2)C=2N(C=NC=2)C)=C1 PXKAGPRBYRFSTO-UHFFFAOYSA-N 0.000 description 1
- 101100281516 Caenorhabditis elegans fox-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QLUPCYKOYKNIOP-UHFFFAOYSA-N Cl.Cl.N1(CCCCC1)C(=O)O Chemical compound Cl.Cl.N1(CCCCC1)C(=O)O QLUPCYKOYKNIOP-UHFFFAOYSA-N 0.000 description 1
- CKYPZCHSASVKPN-UHFFFAOYSA-N Cl.FC=1C=C(COC(C2=CC=C(C(=C2)C2=C(C=CC=C2)C)C#N)C2=CN=CN2C)C=C(C1)F Chemical compound Cl.FC=1C=C(COC(C2=CC=C(C(=C2)C2=C(C=CC=C2)C)C#N)C2=CN=CN2C)C=C(C1)F CKYPZCHSASVKPN-UHFFFAOYSA-N 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- 206010011017 Corneal graft rejection Diseases 0.000 description 1
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical group F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 102100028701 General vesicular transport factor p115 Human genes 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
- 101000767151 Homo sapiens General vesicular transport factor p115 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101710163622 Isoprenyl transferase Proteins 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- MRLVFVTVXSKAMX-UHFFFAOYSA-N Methyl 4-amino-3-iodobenzoate Chemical compound COC(=O)C1=CC=C(N)C(I)=C1 MRLVFVTVXSKAMX-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- XTUVJUMINZSXGF-UHFFFAOYSA-N N-methylcyclohexylamine Chemical group CNC1CCCCC1 XTUVJUMINZSXGF-UHFFFAOYSA-N 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical group CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 208000005890 Neuroma Diseases 0.000 description 1
- 101100513046 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) eth-1 gene Proteins 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- MSHZHSPISPJWHW-UHFFFAOYSA-N O-(chloroacetylcarbamoyl)fumagillol Chemical compound O1C(CC=C(C)C)C1(C)C1C(OC)C(OC(=O)NC(=O)CCl)CCC21CO2 MSHZHSPISPJWHW-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910020667 PBr3 Inorganic materials 0.000 description 1
- 208000035871 PIK3CA-related overgrowth syndrome Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- 102000004211 Platelet factor 4 Human genes 0.000 description 1
- 108090000778 Platelet factor 4 Proteins 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 102000019337 Prenyltransferases Human genes 0.000 description 1
- 108050006837 Prenyltransferases Proteins 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000007135 Retinal Neovascularization Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
- 208000000389 T-cell leukemia Diseases 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- PKDFKUQMASHQQO-UHFFFAOYSA-N [1-(ethoxymethyl)imidazol-2-yl]-triethylsilane Chemical compound CCOCN1C=CN=C1[Si](CC)(CC)CC PKDFKUQMASHQQO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- DBGROTRFYBSUTR-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]methanamine Chemical compound NCC1=CC=C(OC(F)(F)F)C=C1 DBGROTRFYBSUTR-UHFFFAOYSA-N 0.000 description 1
- SNJOAXHUVLUDHC-UHFFFAOYSA-N [4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]phenyl]-diazonioazanide Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(N=[N+]=[N-])C=C1 SNJOAXHUVLUDHC-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- YUENFNPLGJCNRB-UHFFFAOYSA-N anthracen-1-amine Chemical compound C1=CC=C2C=C3C(N)=CC=CC3=CC2=C1 YUENFNPLGJCNRB-UHFFFAOYSA-N 0.000 description 1
- DYBXVITUBPGBBW-UHFFFAOYSA-N anthracen-1-ylboronic acid Chemical compound C1=CC=C2C=C3C(B(O)O)=CC=CC3=CC2=C1 DYBXVITUBPGBBW-UHFFFAOYSA-N 0.000 description 1
- VHHDLIWHHXBLBK-UHFFFAOYSA-N anthracen-9-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=C(C=CC=C3)C3=CC2=C1 VHHDLIWHHXBLBK-UHFFFAOYSA-N 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- HUMNYLRZRPPJDN-KWCOIAHCSA-N benzaldehyde Chemical group O=[11CH]C1=CC=CC=C1 HUMNYLRZRPPJDN-KWCOIAHCSA-N 0.000 description 1
- UDSRUCAJZSIRHZ-UHFFFAOYSA-N benzamide dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1.NC(=O)C1=CC=CC=C1 UDSRUCAJZSIRHZ-UHFFFAOYSA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 125000000928 benzodioxinyl group Chemical group O1C(=COC2=C1C=CC=C2)* 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- CNJPMAQLHBUXSI-UHFFFAOYSA-N benzyl 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]piperidine-1-carboxylate Chemical compound CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NC1CCN(C(=O)OCC=2C=CC=CC=2)CC1 CNJPMAQLHBUXSI-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- PPDJNZTUDFPAHX-UHFFFAOYSA-N benzyltrimethylammonium dichloroiodate Chemical compound Cl[I-]Cl.C[N+](C)(C)CC1=CC=CC=C1 PPDJNZTUDFPAHX-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- MDQDBTCGQGXTBP-UHFFFAOYSA-N bromomethyl benzoate Chemical compound BrCOC(=O)C1=CC=CC=C1 MDQDBTCGQGXTBP-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- XJHCXCQVJFPJIK-UHFFFAOYSA-M cesium fluoride Substances [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- VSSAZBXXNIABDN-UHFFFAOYSA-N cyclohexylmethanol Chemical compound OCC1CCCCC1 VSSAZBXXNIABDN-UHFFFAOYSA-N 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- GJVIVAYVYHUGOO-UHFFFAOYSA-N dimethyl 2-iodobenzene-1,4-dicarboxylate Chemical group COC(=O)C1=CC=C(C(=O)OC)C(I)=C1 GJVIVAYVYHUGOO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RWLODLINFJTZEE-UHFFFAOYSA-N ethyl 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1NC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C RWLODLINFJTZEE-UHFFFAOYSA-N 0.000 description 1
- NOGUJGZZMMKQOZ-UHFFFAOYSA-N ethyl 4-amino-3-bromobenzoate Chemical compound CCOC(=O)C1=CC=C(N)C(Br)=C1 NOGUJGZZMMKQOZ-UHFFFAOYSA-N 0.000 description 1
- ICFCBYVKPRHTPR-UHFFFAOYSA-N ethyl 4-amino-3-iodobenzoate Chemical compound CCOC(=O)C1=CC=C(N)C(I)=C1 ICFCBYVKPRHTPR-UHFFFAOYSA-N 0.000 description 1
- BMSHEKLIJUVUAX-UHFFFAOYSA-N ethyl 4-cyano-3-(2-methoxyphenyl)benzoate Chemical compound CCOC(=O)C1=CC=C(C#N)C(C=2C(=CC=CC=2)OC)=C1 BMSHEKLIJUVUAX-UHFFFAOYSA-N 0.000 description 1
- LCJPXYMWIJIZKN-UHFFFAOYSA-N ethyl 4-cyano-3-(3-methylphenyl)benzoate Chemical compound CCOC(=O)C1=CC=C(C#N)C(C=2C=C(C)C=CC=2)=C1 LCJPXYMWIJIZKN-UHFFFAOYSA-N 0.000 description 1
- GXPMQJCEXVJUBD-UHFFFAOYSA-N ethyl 4-cyano-3-(5,6,7,8-tetrahydronaphthalen-1-yl)benzoate Chemical compound CCOC(=O)C1=CC=C(C#N)C(C=2C=3CCCCC=3C=CC=2)=C1 GXPMQJCEXVJUBD-UHFFFAOYSA-N 0.000 description 1
- IEZBSAYNSUQGIR-UHFFFAOYSA-N ethyl 4-cyano-3-naphthalen-1-ylbenzoate Chemical compound CCOC(=O)C1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 IEZBSAYNSUQGIR-UHFFFAOYSA-N 0.000 description 1
- LUBGFMZTGFXIIN-UHFFFAOYSA-N ethyl 4-oxopiperidine-1-carboxylate Chemical group CCOC(=O)N1CCC(=O)CC1 LUBGFMZTGFXIIN-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 230000009033 hematopoietic malignancy Effects 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WFNASTYGEKUMIY-UHFFFAOYSA-N hydron;1h-imidazol-5-ylmethanol;chloride Chemical compound Cl.OCC1=CN=CN1 WFNASTYGEKUMIY-UHFFFAOYSA-N 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- 239000012616 hydrophobic interaction chromatography medium Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XKEYHBLSCGBBGU-UHFFFAOYSA-N isoquinolin-5-ylboronic acid Chemical compound N1=CC=C2C(B(O)O)=CC=CC2=C1 XKEYHBLSCGBBGU-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- FZRBKIRIBLNOAM-WHVZTFIZSA-N kinoprene Chemical group CC(C)CCCC(C)C\C=C\C(\C)=C\C(=O)OCC#C FZRBKIRIBLNOAM-WHVZTFIZSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- DMSVSKHQVHBCGJ-UHFFFAOYSA-M lithium;4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoate Chemical compound [Li+].CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)OCC1=CC=C(C([O-])=O)C=C1 DMSVSKHQVHBCGJ-UHFFFAOYSA-M 0.000 description 1
- MIDMYXSRYGJVIR-UHFFFAOYSA-M lithium;4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]benzoate Chemical compound [Li+].CN1C=NC=C1C(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)NCC1=CC=C(C([O-])=O)C=C1 MIDMYXSRYGJVIR-UHFFFAOYSA-M 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 210000005001 male reproductive tract Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 208000011645 metastatic carcinoma Diseases 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 208000037843 metastatic solid tumor Diseases 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- YUHSMQQNPRLEEJ-UHFFFAOYSA-N methyl 3-(bromomethyl)benzoate Chemical group COC(=O)C1=CC=CC(CBr)=C1 YUHSMQQNPRLEEJ-UHFFFAOYSA-N 0.000 description 1
- SSLZWKSTJSVWDJ-UHFFFAOYSA-N methyl 3-[[4-cyano-n-[(3-methylimidazol-4-yl)methyl]-3-naphthalen-1-ylanilino]methyl]benzoate Chemical compound COC(=O)C1=CC=CC(CN(CC=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C3=CC=CC=C3C=CC=2)=C1 SSLZWKSTJSVWDJ-UHFFFAOYSA-N 0.000 description 1
- FWFLHVYHVXAPTN-UHFFFAOYSA-N methyl 3-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]benzoate Chemical compound COC(=O)C1=CC=CC(COC(C=2N(C=NC=2)C)C=2C=C(C(C#N)=CC=2)C=2C(=CC=CC=2)C)=C1 FWFLHVYHVXAPTN-UHFFFAOYSA-N 0.000 description 1
- KDNFJYKKFLHZKZ-UHFFFAOYSA-N methyl 3-chloro-4-cyanobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C(Cl)=C1 KDNFJYKKFLHZKZ-UHFFFAOYSA-N 0.000 description 1
- NLWBJPPMPLPZIE-UHFFFAOYSA-N methyl 4-(bromomethyl)benzoate Chemical group COC(=O)C1=CC=C(CBr)C=C1 NLWBJPPMPLPZIE-UHFFFAOYSA-N 0.000 description 1
- ZJWGVHKNUZVSCH-UHFFFAOYSA-N methyl 4-[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C ZJWGVHKNUZVSCH-UHFFFAOYSA-N 0.000 description 1
- NNGYKPZWRSSAOL-UHFFFAOYSA-N methyl 4-[[4-cyano-n-[(3-methylimidazol-4-yl)methyl]-3-naphthalen-1-ylanilino]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CN=CN1C NNGYKPZWRSSAOL-UHFFFAOYSA-N 0.000 description 1
- VEQHWHXNGKADEW-UHFFFAOYSA-N methyl 4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CNC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C VEQHWHXNGKADEW-UHFFFAOYSA-N 0.000 description 1
- DFDFVGRXQMTZKO-UHFFFAOYSA-N methyl 4-[[[4-cyano-3-(2-methylphenyl)phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C)C1=CN=CN1C DFDFVGRXQMTZKO-UHFFFAOYSA-N 0.000 description 1
- LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical group COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 1
- BCWNRNRPONKSDR-UHFFFAOYSA-N methyl 4-cyano-3-(4-methylphenyl)benzoate Chemical compound COC(=O)C1=CC=C(C#N)C(C=2C=CC(C)=CC=2)=C1 BCWNRNRPONKSDR-UHFFFAOYSA-N 0.000 description 1
- SITDHTOGRYGTOO-UHFFFAOYSA-N methyl 4-cyano-3-cyclohexylbenzoate Chemical compound COC(=O)C1=CC=C(C#N)C(C2CCCCC2)=C1 SITDHTOGRYGTOO-UHFFFAOYSA-N 0.000 description 1
- FEIOASZZURHTHB-UHFFFAOYSA-N methyl 4-formylbenzoate Chemical group COC(=O)C1=CC=C(C=O)C=C1 FEIOASZZURHTHB-UHFFFAOYSA-N 0.000 description 1
- PWXMEBZOKUPCST-UHFFFAOYSA-N methyl 5-(chloromethyl)furan-2-carboxylate Chemical group COC(=O)C1=CC=C(CCl)O1 PWXMEBZOKUPCST-UHFFFAOYSA-N 0.000 description 1
- MVYNZESWYVPPFF-UHFFFAOYSA-N methyl 6-[[(4-cyano-3-naphthalen-1-ylphenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CN=CN1C MVYNZESWYVPPFF-UHFFFAOYSA-N 0.000 description 1
- QHBMFMYUGXTEEV-UHFFFAOYSA-N methyl 6-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1CNC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C QHBMFMYUGXTEEV-UHFFFAOYSA-N 0.000 description 1
- DZXNOBGIMAGUSX-UHFFFAOYSA-N methyl 6-[[[4-cyano-3-[2-(trifluoromethyl)phenyl]phenyl]-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1COC(C=1C=C(C(C#N)=CC=1)C=1C(=CC=CC=1)C(F)(F)F)C1=CN=CN1C DZXNOBGIMAGUSX-UHFFFAOYSA-N 0.000 description 1
- BZOWIADSJYMJJJ-UHFFFAOYSA-N methyl 6-formylpyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(C=O)N=C1 BZOWIADSJYMJJJ-UHFFFAOYSA-N 0.000 description 1
- SBEUFCDWQQMJHF-UHFFFAOYSA-N methyl 8-(chloromethyl)-4h-1,3-benzodioxine-6-carboxylate Chemical group O1COCC2=CC(C(=O)OC)=CC(CCl)=C21 SBEUFCDWQQMJHF-UHFFFAOYSA-N 0.000 description 1
- OLXYLDUSSBULGU-UHFFFAOYSA-N methyl pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC=C1 OLXYLDUSSBULGU-UHFFFAOYSA-N 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 201000005987 myeloid sarcoma Diseases 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UQEIFYRRSNJVDO-UHFFFAOYSA-N n,n-dibenzyl-2-phenylethanamine Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)CCC1=CC=CC=C1 UQEIFYRRSNJVDO-UHFFFAOYSA-N 0.000 description 1
- KQXDJQMJSLGBDM-UHFFFAOYSA-N n-(4-cyano-3-naphthalen-1-ylphenyl)-n-[(3-methylimidazol-4-yl)methyl]benzamide Chemical compound CN1C=NC=C1CN(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C(=O)C1=CC=CC=C1 KQXDJQMJSLGBDM-UHFFFAOYSA-N 0.000 description 1
- INVYLRFQZDSPQW-UHFFFAOYSA-N n-(4-cyano-3-naphthalen-1-ylphenyl)-n-[(3-methylimidazol-4-yl)methyl]benzenesulfonamide Chemical compound CN1C=NC=C1CN(S(=O)(=O)C=1C=CC=CC=1)C1=CC=C(C#N)C(C=2C3=CC=CC=C3C=CC=2)=C1 INVYLRFQZDSPQW-UHFFFAOYSA-N 0.000 description 1
- OBGJOOYUTASOOF-UHFFFAOYSA-N n-[4-[[(4-cyano-3-naphthalen-1-ylphenyl)methyl-[(3-methylimidazol-4-yl)methyl]amino]methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CN(CC=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)CC1=CN=CN1C OBGJOOYUTASOOF-UHFFFAOYSA-N 0.000 description 1
- YHNXERVMFKIJSS-UHFFFAOYSA-N n-[4-[[[(4-cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methyl]amino]methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CNC(C=1C=C(C(C#N)=CC=1)C=1C2=CC=CC=C2C=CC=1)C1=CN=CN1C YHNXERVMFKIJSS-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HUMMCEUVDBVXTQ-UHFFFAOYSA-N naphthalen-1-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CC=CC2=C1 HUMMCEUVDBVXTQ-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 201000003142 neovascular glaucoma Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- SEVSMVUOKAMPDO-UHFFFAOYSA-N para-Acetoxybenzaldehyde Natural products CC(=O)OC1=CC=C(C=O)C=C1 SEVSMVUOKAMPDO-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940043138 pentosan polysulfate Drugs 0.000 description 1
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229950010765 pivalate Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940056457 promace Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- KATIRQRAVXTBNY-UHFFFAOYSA-N quinolin-4-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CC=NC2=C1 KATIRQRAVXTBNY-UHFFFAOYSA-N 0.000 description 1
- VCKUOSKDXLTBDG-UHFFFAOYSA-N quinolinone A Natural products COC1C(=O)NC2=CC=CC=C2C1(O)C1=CC=C(OC)C=C1 VCKUOSKDXLTBDG-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- 108700042226 ras Genes Proteins 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- CXEMWUYNUIKMNF-UHFFFAOYSA-N tert-butyl 4-chlorosulfonylpiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(S(Cl)(=O)=O)CC1 CXEMWUYNUIKMNF-UHFFFAOYSA-N 0.000 description 1
- ACNRTYKOPZDRCO-UHFFFAOYSA-N tert-butyl n-(2-oxoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC=O ACNRTYKOPZDRCO-UHFFFAOYSA-N 0.000 description 1
- VAIAZXXBIBVQMB-UHFFFAOYSA-N tert-butyl n-[2-[3-(trifluoromethoxy)anilino]ethyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCNC1=CC=CC(OC(F)(F)F)=C1 VAIAZXXBIBVQMB-UHFFFAOYSA-N 0.000 description 1
- LROUBCOBLAPPAT-UHFFFAOYSA-N tert-butyl-(3-chloropropoxy)-dimethylsilane Chemical group CC(C)(C)[Si](C)(C)OCCCCl LROUBCOBLAPPAT-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 229960003433 thalidomide Drugs 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- QNMBSXGYAQZCTN-UHFFFAOYSA-N thiophen-3-ylboronic acid Chemical compound OB(O)C=1C=CSC=1 QNMBSXGYAQZCTN-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000006208 topical dosage form Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- VFJYIHQDILEQNR-UHFFFAOYSA-M trimethylsulfanium;iodide Chemical compound [I-].C[S+](C)C VFJYIHQDILEQNR-UHFFFAOYSA-M 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000003741 urothelium Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- PVURAUIMVICLOH-UHFFFAOYSA-M zinc;cyclohexane;bromide Chemical compound Br[Zn+].C1CC[CH-]CC1 PVURAUIMVICLOH-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56325600A | 2000-04-27 | 2000-04-27 | |
US09/563,256 | 2000-04-27 | ||
US82220501A | 2001-04-02 | 2001-04-02 | |
US09/822,205 | 2001-04-02 | ||
PCT/US2001/013678 WO2001081316A2 (en) | 2000-04-27 | 2001-04-25 | Substituted phenyl farnesyltransferase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2407093A1 true CA2407093A1 (en) | 2001-11-01 |
Family
ID=27073227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002407093A Abandoned CA2407093A1 (en) | 2000-04-27 | 2001-04-25 | Substituted phenyl farnesyltransferase inhibitors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1276726A2 (es) |
JP (1) | JP2004509064A (es) |
AU (1) | AU2001259218A1 (es) |
CA (1) | CA2407093A1 (es) |
HK (1) | HK1053833A1 (es) |
MX (1) | MXPA02010608A (es) |
PE (1) | PE20011318A1 (es) |
WO (1) | WO2001081316A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US7408063B2 (en) * | 2001-12-19 | 2008-08-05 | Janssen Pharmaceutica, N.V. | 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
US6989382B2 (en) | 2002-10-21 | 2006-01-24 | Chiron Corporation | Carbocycle based inhibitors of glycogen synthase kinase 3 |
WO2005012256A1 (en) | 2003-07-22 | 2005-02-10 | Astex Therapeutics Limited | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
AU2005230846A1 (en) | 2004-03-31 | 2005-10-20 | Lexicon Pharmaceuticals, Inc. | 2-aminomethylthiazole-5-carboxamides as protein kinase modulators |
US7309709B2 (en) * | 2004-04-01 | 2007-12-18 | Pfizer Inc. | Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
AR054425A1 (es) | 2005-01-21 | 2007-06-27 | Astex Therapeutics Ltd | Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico. |
TW200806284A (en) * | 2006-03-31 | 2008-02-01 | Alcon Mfg Ltd | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
EA017029B1 (ru) | 2007-04-06 | 2012-09-28 | Ньюрокрайн Байосайенсиз, Инк. | Антагонисты рецептора гонадотропин-рилизинг-фактора и способы их применения |
WO2012177896A1 (en) | 2011-06-24 | 2012-12-27 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
PE20140868A1 (es) | 2011-06-24 | 2014-07-18 | Amgen Inc | Antagonistas trpm8 y su uso en tratamientos |
US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
KR20200030584A (ko) | 2017-07-21 | 2020-03-20 | 앤타바이오 에스에이에스 | 화합물 |
WO2019236879A1 (en) * | 2018-06-07 | 2019-12-12 | Disarm Therapeutics, Inc. | Inhibitors of sarm1 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8961382A (en) * | 1981-11-06 | 1983-05-12 | Imperial Chemical Industries Plc | Amide derivatives |
JP2868883B2 (ja) * | 1990-10-15 | 1999-03-10 | 株式会社トクヤマ | ジオキソラン誘導体 |
US5733666A (en) * | 1995-08-23 | 1998-03-31 | Wayne Pigment Corp. | Aqueous sealer composition for wood surfaces and process |
US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
EP1091736A4 (en) * | 1998-07-02 | 2001-10-24 | Merck & Co Inc | INHIBITORS OF PRENYL PROTEIN TRANSFERASE |
-
2001
- 2001-04-25 WO PCT/US2001/013678 patent/WO2001081316A2/en not_active Application Discontinuation
- 2001-04-25 CA CA002407093A patent/CA2407093A1/en not_active Abandoned
- 2001-04-25 MX MXPA02010608A patent/MXPA02010608A/es unknown
- 2001-04-25 EP EP01932712A patent/EP1276726A2/en not_active Withdrawn
- 2001-04-25 JP JP2001578410A patent/JP2004509064A/ja not_active Withdrawn
- 2001-04-25 AU AU2001259218A patent/AU2001259218A1/en not_active Abandoned
- 2001-04-27 PE PE2001000384A patent/PE20011318A1/es not_active Application Discontinuation
-
2003
- 2003-06-23 HK HK03104500.2A patent/HK1053833A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1276726A2 (en) | 2003-01-22 |
HK1053833A1 (zh) | 2003-11-07 |
JP2004509064A (ja) | 2004-03-25 |
AU2001259218A1 (en) | 2001-11-07 |
PE20011318A1 (es) | 2002-01-08 |
MXPA02010608A (es) | 2003-05-14 |
WO2001081316A2 (en) | 2001-11-01 |
WO2001081316A3 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020019527A1 (en) | Substituted phenyl farnesyltransferase inhibitors | |
CA2407093A1 (en) | Substituted phenyl farnesyltransferase inhibitors | |
CA2677313C (en) | Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases | |
JP5001505B2 (ja) | 新規チオウレア誘導体およびこれを含有する薬学的組成物 | |
AU2016380349B2 (en) | Metalloenzyme inhibitor compounds | |
RU2274639C2 (ru) | Производные замещенного триазолдиамина, фармацевтическая композиция на их основе и способ ее получения | |
US7323570B2 (en) | Farnesyltransferase inhibitors | |
CA2200981A1 (en) | Urea derivatives and their use as acat-inhibitors | |
US20030060473A1 (en) | Piperazine compounds as inhibitors of MMP or TNF | |
EA024385B1 (ru) | Соединения, ингибирующие металлоферменты | |
EP1264820A1 (en) | Novel amide compounds | |
JP2006528939A5 (es) | ||
CA2995675A1 (en) | Heteroaryl compounds and their use as therapeutic drugs | |
KR100467668B1 (ko) | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 | |
DE60118955T2 (de) | Farnesyltransferase inhibitoren | |
CZ227292A3 (en) | Aralkylamino derivatives | |
AU2001297704B2 (en) | Farnesyltransferase inhibitors | |
AU2001297704A1 (en) | Farnesyltransferase inhibitors | |
MXPA05001985A (es) | Derivados de imidazol 2-tio-sustituidos y su uso en farmaceuticos. | |
EP0301456B1 (en) | Novel (aryl or heteroaromatic methyl)-2,2'-BI-1H-imidazoles | |
JPH05194429A (ja) | アゾール化合物、その製造法および用途 | |
AU2008202194A1 (en) | Inhibitors of tyrosine kinases | |
NZ538222A (en) | 2-Thio-substituted imidazole derivatives and their use in pharmaceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |